JAX Mouse Strain Datasheet - 002251

B6.129P2-Il10^tm1Cgn/J

Stock No:: 002251 |; Il-10 KO

Available Now

Overview

Also Known As: Il-10 KO

B6.129P2-Il10^tm1Cgn/J mutant mice spontaneously develop a chronic inflammatory bowel disease (IBD). Il10-deficiency is associated with altered lymphocyte and myeloid profiles, elevated serum amyloid A levels, altered responses to inflammatory or autoimmune stimuli, increased prevalence of colorectal adenocarcinoma, and spontaneous development of chronic enterocolitis. Il10-deficient mice exhibit a significant increase in peripheral blood granulocyte populations upon lesion development.

Donating Investigator

Dr. Sandy Morse, National Institutes of Health

Genetic overview

Genetic Background	Generation
C57BL/6	N13F10 (05-AUG-14)

Il10^tm1Cgn

Allele Type	Gene Symbol	Gene Name
Targeted (Null/Knockout)	Il10	interleukin 10

View Genetics

Research Applications

Cancer Research
Hematological Research
Immunology, Inflammation and Autoimmunity Research

View All Research Applications

Base Price

Starting at:

$124.58 Domestic price for female 3-week

View Price List

Details

Detailed Description

Mice homozygous for the Il10^tm1Cgn targeted mutation are viable and fertile when housed under specific pathogen free (SPF) conditions. Under conventional housing conditions, Il10-deficiency is associated with altered lymphocyte and myeloid profiles, elevated serum amyloid A levels, altered responses to inflammatory or autoimmune stimuli (both endogenous and induced), increased prevalence of colorectal adenocarcinoma (especially on 129/Sv and, to a lesser extent, BALB/c genetic background), and spontaneous development of chronic enterocolitis (see below). As The Jackson Laboratory Repository maintains these mice at high health status conditions (high SPF), the observed or experimentally-induced Il10-deficient phenotype may vary from that previously published using mice from conventional mouse rooms. These IL-10 mutant mice may be useful studying inflammatory bowel disease (IBD) (Crohn's disease (CD) and/or colitis), cancer, innate and adaptive immunity, and many other areas of inflammatory or autoimmunity research.

The onset and severity of both spontaneous and experimentally-induced inflammatory phenotype of Il10-deficient mice is strongly influenced by the genetic background and the husbandry conditions (specific health status/commensal flora) of the vivaria in which mice are maintained.

For example, inflammatory bowel disease (IBD; colitis and Crohn's disease) severity in mouse models is dependent upon interactions between specific genetic background and environmental factors (an as yet undefined component of the enteric flora of which Helicobacter spp. appear to be associated, but not specifically the environmental trigger). Both spontaneous and induced models of IBD demonstrate that susceptibility to intestinal inflammation varies markedly among inbred strains of mice. Generally, for Il10-deficient models on defined genetic backgrounds, the severity of colitis-related characteristics is most severe on C3H/HeJBir (Stock No. 004326 and Stock No. 003968) or 129/Sv (Stock No. 004368), intermediate on BALB/cJ (Stock No. 004333) or NOD/Lt (Stock No. 004266), and least severe on C57BL/10 (Stock No. 002250) or C57BL/6J (Stock No. 002251). Furthermore, the husbandry conditions (specific health status/commensal flora) of the vivaria in which mice are maintained significantly alter the onset and severity of spontaneous IBD; higher SPF conditions are associated with attenuated colitis. Il10-deficient mice on both the C3H/HeJBir and C57BL/6J genetic backgrounds exhibit a significant increase in peripheral blood granulocyte populations upon lesion development and this metric may be used as a robust non-lethal assessment of Il10-deficiency induced colitis onset and severity. Other indications of Il10-deficiency induced colitic lesion onset may include perianal ulceration (C3H/HeJBir background) or rectal prolapse (C57BL/6J background).

Development

The Il10^tm1Cgn mutation was created by in the Laboratory of Dr. Werner Muller at the University of Cologne. Briefly, a targeting vector was designed to replace codons 5-55 of exon 1 of the targeted gene with a 24 bp linker (providing a termination codon) and a neo expression cassette, as well as introduce a termination codon into exon 3. The construct was electroporated into 129P2/OlaHsd-derived E14-1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient C57BL/6 blastocysts and chimeric males were bred with C57BL/6 females to establish the mutant colony on a mixed B6;129P2 genetic background. Subsequently, mutant mice were backcrossed to the C57BL/6J genetic background for several generations to generate this strain.

Control Suggestions

000664 C57BL/6J

Additional Information

Considerations for Choosing Controls

Selected References

Kuhn R; Lohler J; Rennick D; Rajewsky K; Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis [see comments] Cell 75(2):263-74. PubMed: 8402911 MGI: J:15222

View All References

Genetics

Il10^tm1Cgn

Allele Symbol: Il10^tm1Cgn

Allele Name	targeted mutation 1, University of Cologne
Allele Type	Targeted (Null/Knockout)
Allele Synonym(s)	IL-10 KO; IL-10-; IL-10^KO; IL-10KO; Il10-; Il10^tmCgn
Gene Symbol and Name	Il10, interleukin 10
Gene Synonym(s)	CSIF; GVHDS; IL-10; IL10A; IL10X; Il-10; TGIF; cytokine synthesis inhibitory factor
Strain of Origin	129P2/OlaHsd
Chromosome	1
Molecular Note	A 500 bp genomic fragment containing codons 5-55 was replaced with a linker containing a termination codon followed by a neomycin cassette. A termination codon was also introduced into exon 3. No IL10 activity was detectable by ELISA assays in supernatants of in vitro cultures of Con A-stimulated splenic T cells derived from homozygous mice following infection with the nematode N. brasiliensis.
Mutations Made By	Dr. Ralf Kuhn, University of Cologne

Disease/Phenotype

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Il10^tm1Cgn related

Cancer Research
- Growth Factors/Receptors/Cytokines
Hematological Research
- Anemia, Iron Deficiency and Transport Defects
  - hemolytic
- Immunological Defects
Immunology, Inflammation and Autoimmunity Research
- Autoimmunity
- Growth Factors/Receptors/Cytokines
- Immunodeficiency
- Inflammation
  - Inflammatory bowel disease

Mammalian Phenotype Terms by Genotype

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
B6.129P2-Il10^tm1Cgn

immune system phenotype

abnormal circulating interleukin-12b level
- PGE2 represses LPS induction to a lesser extent than it does in controls

abnormal circulating interleukin-6 level
- PGE2 represses LPS induction to a lesser extent than it does in controls

homeostasis/metabolism phenotype

abnormal circulating interleukin-12b level
- PGE2 represses LPS induction to a lesser extent than it does in controls

abnormal circulating interleukin-6 level
- PGE2 represses LPS induction to a lesser extent than it does in controls

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
B6.129P2-Il10^tm1Cgn/J

growth/size/body region phenotype

slow postnatal weight gain
- lower body weight gain between 5 and 10 weeks of age than for controls

neoplasm

increased colon adenocarcinoma incidence
- 20% of mutants with colonic inflammation exhibit colon tumors; tumors are adenocarcinomas
- tumors develop between 25 and 35 weeks of age

cellular phenotype

increased susceptibility to neuronal excitotoxicity
- increased toxicity of N-methyl-D-aspartate in primary neuron culture

hematopoietic system phenotype

abnormal regulatory T cell physiology
- CD25-positive CD4 T cells from these mice fail to protect against the wasting disease induced by transferring nave CD4 T cells into immunodeficient hosts
- however, CD25-postive CD4 T cells inhibit the expansion of naive T cells in Rag2 deficient hosts as effectively as wild-type CD25-positive CD4 T cells

immune system phenotype

abnormal chemokine level
- LPS-injected mice exhibit increased CXCL10 and CXCL1 levels compared with similarly treated wild-type mice

abnormal cytokine level
- in LPS-injected mice
- levels of cytokines increase in the brain are greater than for controls after lipopolysaccharide treatment

abnormal regulatory T cell physiology
- CD25-positive CD4 T cells from these mice fail to protect against the wasting disease induced by transferring nave CD4 T cells into immunodeficient hosts
- however, CD25-postive CD4 T cells inhibit the expansion of naive T cells in Rag2 deficient hosts as effectively as wild-type CD25-positive CD4 T cells

cecum inflammation
- mice infected with T. muris exhibit increased worm burden and cecum score compared with similarly treated wild-type mice

increased circulating interferon-gamma level
- in LPS-injected mice

increased circulating interleukin-1 alpha level
- in LPS-injected mice

increased circulating interleukin-1 beta level
- in LPS-injected mice
- plasma levels remain elevated for 24 hours after lipopolysaccharide treatment as opposed to 4 hours for controls

increased circulating interleukin-12 level
- in LPS-injected mice

increased circulating interleukin-17 level
- in LPS-injected mice

increased circulating interleukin-2 level
- in LPS-injected mice

increased circulating interleukin-6 level
- plasma levels remain elevated for 24 hours after lipopolysaccharide treatment as opposed to 4 hours for controls
- slightly in LPS-injected mice

increased circulating tumor necrosis factor level
- in LPS-injected mice

increased susceptibility to induced colitis
- upon DSS exposure

increased susceptibility to parasitic infection
- mice infected with T. muris exhibit increased worm burden and cecum score compared with similarly treated wild-type mice

large intestinal inflammation
- mutants develop severe inflammation in the colon leading to inflammatory bowel disease

homeostasis/metabolism phenotype

abnormal chemokine level
- LPS-injected mice exhibit increased CXCL10 and CXCL1 levels compared with similarly treated wild-type mice

abnormal cytokine level
- in LPS-injected mice
- levels of cytokines increase in the brain are greater than for controls after lipopolysaccharide treatment

impaired adaptive thermogenesis
- lipopolysaccharide causes a very significant drop in core body temperature

impaired exercise endurance
- time to fatigue on a motorized treadmill is reduced 24% after lipopolysaccharide treatment

increased cerebral infarction size
- lesion volume after middle cerebral artery occlusion increases 30%

increased circulating interferon-gamma level
- in LPS-injected mice

increased circulating interleukin-1 alpha level
- in LPS-injected mice

increased circulating interleukin-1 beta level
- in LPS-injected mice
- plasma levels remain elevated for 24 hours after lipopolysaccharide treatment as opposed to 4 hours for controls

increased circulating interleukin-12 level
- in LPS-injected mice

increased circulating interleukin-17 level
- in LPS-injected mice

increased circulating interleukin-2 level
- in LPS-injected mice

increased circulating interleukin-6 level
- plasma levels remain elevated for 24 hours after lipopolysaccharide treatment as opposed to 4 hours for controls
- slightly in LPS-injected mice

increased circulating tumor necrosis factor level
- in LPS-injected mice

increased susceptibility to neuronal excitotoxicity
- increased toxicity of N-methyl-D-aspartate in primary neuron culture

digestive/alimentary phenotype

cecum inflammation
- mice infected with T. muris exhibit increased worm burden and cecum score compared with similarly treated wild-type mice

increased colon adenocarcinoma incidence
- 20% of mutants with colonic inflammation exhibit colon tumors; tumors are adenocarcinomas
- tumors develop between 25 and 35 weeks of age

increased susceptibility to induced colitis
- upon DSS exposure

large intestinal inflammation
- mutants develop severe inflammation in the colon leading to inflammatory bowel disease

rectal prolapse
- rectal prolapse is seen at a median time of 16 weeks of age

cardiovascular system phenotype

decreased mean systemic arterial blood pressure
- lower under basal conditions

decreased susceptibility to induced choroidal neovascularization
- reduced choroidal neovascularization 7 days following krypton laser exposure of the eye

decreased vasoconstriction
- LPS treatment markedly impairs contractions of the carotid artery induced by the thromboxane analogue U46619 and by phenylephrine

increased vasoconstriction
- endothelin 1 induced contraction of Aorta and first order mesenteric arteries is greater than controls when also treated with L-NAME and indomethecine and TNFalpha
- response to endothelin 1 is eliminated in the presence of PD-98059

muscle phenotype

decreased vasoconstriction
- LPS treatment markedly impairs contractions of the carotid artery induced by the thromboxane analogue U46619 and by phenylephrine

increased vasoconstriction
- endothelin 1 induced contraction of Aorta and first order mesenteric arteries is greater than controls when also treated with L-NAME and indomethecine and TNFalpha
- response to endothelin 1 is eliminated in the presence of PD-98059

behavior/neurological phenotype

abnormal sleep pattern
- less effect of influenza virus infection on slow wave sleep during dark phase but a greater decrease in delta wave amplitude
- lipopolysaccharide causes an overall decrease in delta wave amplitude
- lipopolysaccharide causes decreased slow wave and REM sleep during light phase
- lipopolysaccharide results in increased time spent awake, particularly in light phase
- more time in "slow-wave sleep" and less time awake during dark phase

impaired coordination
- effect persists at least 24 hours
- performance fails to improve over consecutive trials but only after IP lipopolysaccharide injection
- rotarod performance worsens after IP lipopolysaccharide injection

impaired exercise endurance
- time to fatigue on a motorized treadmill is reduced 24% after lipopolysaccharide treatment

nervous system phenotype

abnormal neuron physiology
- increased sensitivity to oxygen or glucose deprivation

increased cerebral infarction size
- lesion volume after middle cerebral artery occlusion increases 30%

increased susceptibility to neuronal excitotoxicity
- increased toxicity of N-methyl-D-aspartate in primary neuron culture

vision/eye phenotype

decreased susceptibility to induced choroidal neovascularization
- reduced choroidal neovascularization 7 days following krypton laser exposure of the eye

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd

reproductive system phenotype

abnormal reproductive system physiology
- mice treated with Gal1 exhibit less protection from stress-induced fetal loss compared to similarly treated wild-type mice

immune system phenotype

abnormal cytokine secretion
- 6 hours after LPS injection, TNF, Il12 and Ifng levels are substantially higher than in controls

abnormal inflammatory response
- 5 days after flank injection of CpG, mice develop solid subcutaneous swellings at the injection site; lesions show conspicuous edema, massive infiltration by macrophages and neutrophilic granulocytes, and extensive necrosis of the dermis, epidermis and muscle layer of the skin while lesions in controls do not display edema or necrosis and show infiltration by macrophages primarilyscle layer of the skin while lesions in controls do not display edema or necrosis and show infiltration by macrophages primarily
- after three subcutaneous injections of LPS into the flank, mice develop solid subcutaneous swellings whereas wild-type do not
- lesion is associated with infiltration of macrophages and neutrophils, edema, and extensive necrosis of dermal, epidermal, and muscle layers of skin

increased circulating interleukin-12 level
- in LPS-treated mice

increased circulating tumor necrosis factor level
- in LPS-treated mice

increased susceptibility to endotoxin shock
- LPS-treated mice exhibit uncontrollable release of IL12 and TNF-alpha compared with wild-type mice
- i.p. injection of LPS results in death in all animal by 48 hours, compared to survival of 23/25 controls

intestinal inflammation
- mice show exaggerated inflammatory response upon exposure to CML-mps-containing eluate compared to control

digestive/alimentary phenotype

intestinal inflammation
- mice show exaggerated inflammatory response upon exposure to CML-mps-containing eluate compared to control

rectal prolapse
- 7% of mutants develop rectal prolapse at 16 weeks of age

homeostasis/metabolism phenotype

increased circulating interleukin-12 level
- in LPS-treated mice

increased circulating tumor necrosis factor level
- in LPS-treated mice

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd * C57BL/6 * DBA/1

growth/size/body region phenotype

decreased body weight
- lower body weight than controls

digestive/alimentary phenotype

colitis
- epithelial hyperplasia
- increased lymphocytes in the lamina propria
- inflamatory cells in the mucosa
- reduced mucin producing goblet cells

immune system phenotype

colitis
- epithelial hyperplasia
- increased lymphocytes in the lamina propria
- inflamatory cells in the mucosa
- reduced mucin producing goblet cells

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd * 129S/SvEv

growth/size/body region phenotype

decreased body weight
- mice older than 4 weeks weigh significantly less than controls

digestive/alimentary phenotype

abnormal intestine physiology
- colonic iNOS production increases with age after 4 weeks
- ileal permeability to mannitol 3X higher than in controls at 2 weeks but normal at 6 weeks
- increased colon permeability to mannitol at 2, 4, and 10weeks but not under germ free conditions
- more IFNgamma and TNFalpha produced in the ileum and colon than in controls

colitis
- mild colitis at 4 weeks which plateaus by 8 weeks
- no colitis when raised in germ free conditions
- no ileal injury through 16 weeks

immune system phenotype

colitis
- mild colitis at 4 weeks which plateaus by 8 weeks
- no colitis when raised in germ free conditions
- no ileal injury through 16 weeks

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
B10.129P2(B6)-Il10^tm1Cgn/J

immune system phenotype

decreased length of allograft survival
- acute rejection severity of cardiac allografts (BALB/c) is increased compared to wild-type controls
- decrease in survival times of heart transplants from BALB/c mice after a 30 day course of anti-CD4 and anti-CD8 mAb

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
129S.Cg-Il10^tm1Cgn

cardiovascular system phenotype

decreased vasoconstriction
- LPS treatment markedly impairs contractions of the carotid artery induced by the thromboxane analogue U46619 and by phenylephrine

muscle phenotype

decreased vasoconstriction
- LPS treatment markedly impairs contractions of the carotid artery induced by the thromboxane analogue U46619 and by phenylephrine

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd * C57BL/6

mortality/aging

premature death
- at >3 months of age, mortality is increased but never reaches 100%
- death is correlated with anemia and gradual weight loss
- ~30% of homozygotes succumb to disease within 3 months of age

behavior/neurological phenotype

increased thermal nociceptive threshold
- latency to paw-licking is significantly longer on a hot plate test

cardiovascular system phenotype

abnormal placental labyrinth vasculature morphology
- 26% increase in maternal blood space in the labyrinth
- fetal capillaries are normal

increased myocardial infarction size
- 60% more polymorphonuclear neutrophiles per unit area in mid-ventricular slices relative to controls
- 90% more necrosis after experimental ischemia and reperfusion than found in controls

craniofacial phenotype

abnormal alveolar process morphology
- 3 fold increase in alveolar bone loss at 30 weeks relative to mice at 6 and 16 weeks

embryo phenotype

abnormal placental labyrinth vasculature morphology
- 26% increase in maternal blood space in the labyrinth
- fetal capillaries are normal

increased placental labyrinth size
- 37% increase in cross-sectional area

limbs/digits/tail phenotype

short femur

liver/biliary system phenotype

abnormal liver physiology
- hepatic glucose production is reduced more than in controls

increased hepatocyte apoptosis
- increased response in liver 4 hours after lipopolysaccharide treatment

increased liver triglyceride level
- 54% increase in hepatic triglycerides relative to controls
- plasma triglycerides not elevated

skeleton phenotype

abnormal alveolar process morphology
- 3 fold increase in alveolar bone loss at 30 weeks relative to mice at 6 and 16 weeks

abnormal bone mineralization
- bone resorption is normal
- cancellous mineral apposition rate and bone formation rate are reduced

abnormal bone structure

abnormal osteoblast differentiation
- 40% fewer mineralized bone-like nodules in bone marrow cell culture
- decreased osteoblast generation in primary bone marrow stromal culture

abnormal skeleton morphology

abnormal skeleton physiology

abnormal trabecular bone morphology
- reduced trabecular bone surface

decreased bone mineral content
- significantly reduced femoral ash weight

decreased bone strength
- femora more fragile in mechanical load tests
- reduced stiffness of femora

decreased bone trabecula number
- reduced trabecular number

decreased compact bone mass
- cortical bone mass reduced

decreased trabecular bone mass
- cancellous bone mass of the tibia significantly decreased
- trabecular bone further reduced in mice with colitis

decreased trabecular bone thickness
- reduced trabecular width

short femur

integument phenotype

increased thermal nociceptive threshold
- latency to paw-licking is significantly longer on a hot plate test

cellular phenotype

abnormal osteoblast differentiation
- 40% fewer mineralized bone-like nodules in bone marrow cell culture
- decreased osteoblast generation in primary bone marrow stromal culture

increased hepatocyte apoptosis
- increased response in liver 4 hours after lipopolysaccharide treatment

digestive/alimentary phenotype

abnormal colon morphology
- colonic prolapse is observed in some older mutants

abnormal crypts of Lieberkuhn morphology

abnormal enterocyte morphology

abnormal intestinal epithelium morphology

abnormal intestinal mucosa morphology
- at 9 weeks, 59% of mice displaying colitis develop a high grade dysplasia of the colonic mucosa

abnormal large intestine morphology
- minimal epithelial hyperplasia at 3 weeks
- prominent epithelial hyperplasia at 3 months

cecum inflammation

colitis
- all Il10-null mice develop colitis by the age of 9 weeks in contrast to wild-type littermates

increased intestinal adenocarcinoma incidence
- at 9 weeks, 13% of homozygotes have adenocarcinomas
- in 10-31 week old animals, there is a 65% incidence of colorectal carcinomas

increased large intestine adenocarcinoma incidence
- 25% with colorectal adenocarcinomas at 3 months
- higher incidence of colorectal cancer at 6 months but no metastasis to lymph nodes

intestinal inflammation
- anemic and underweight homozygotes display enterocolitis involving the entire intestinal tract, duodenum, proximal jejunum, and proximal colon
- inflammation was limited to the proximal colon under specific pathogen free conditions
- spontaneous inflammatory bowel disease (IBD) develops by 5 weeks in some animals

large intestinal inflammation
- lymphocytes and small numbers of neutrophiles as infiltrates in the lamina propria of the cecum, ascending and transverse colon at three weeks
- more ulcerations at 6 months
- multifocal lesions in all regions of the large intestine at three months
- occasional transmural inflammation and crypt abscesses at 3 months

small intestinal inflammation
- 8% with duodenitis at 3 months of age
- increased duodenitis at 6 months

growth/size/body region phenotype

cachexia
- although some homozygotes with slow disease progression show normal body weights up to 12 weeks of age, all homozygotes are eventually affected by weight loss
- at 7-11 weeks of age, most homozygotes display a ~30% weight reduction relative to wild-type controls

postnatal growth retardation
- at 7-11 weeks of age, ~75% of homozygotes are growth retarded relative to wild-type controls
- growth retardation is first observed between 3 and 4 weeks of age

hematopoietic system phenotype

abnormal leukocyte morphology

abnormal level of surface class II molecules

abnormal lymphocyte cell number
- double control levels in the lamina propria

abnormal myelopoiesis
- severely anemic homozygotes display a hyperproliferative myeloid compartment

absent erythroid progenitor cell
- severely anemic homozygotes show complete depletion of eythroid cells in the bone marrow

anemia
- at 7-11 weeks of age, ~90% of homozygotes exhibit anemia, most likely due to iron deficiency
- the observed anemia is most often defined as microcytic or normocytic and hypochromic

decreased T cell proliferation
- reduced proliferative response of CD4+ cells to UVB irradiation

decreased erythrocyte cell number
- at 7-11 weeks of age, ~90% of homozygotes display decreased erythrocyte numbers relative to wild-type controls

decreased hemoglobin content
- at 7-11 weeks of age, ~90% of homozygotes display a reduced hemoglobin concentration in circulating blood

decreased spleen iron level

decreased spleen red pulp amount
- severely anemic homozygotes display hypoplasia of the splenic red pulp

hypochromic anemia

increased CD4-positive, alpha beta T cell number
- activated memory phenotype
- elevated

increased IgE level
- total IgE levels are more than 7-fold higher and serum levels of OVA-specific IgE more than 2-fold higher than in wild-type mice after ovalbumin challenge

increased IgG1 level
- OVA-specific IgG1 levels are higher in ovalbumin-sensitized mutants

increased IgG2a level
- OVA-specific IgG2a levels are higher in ovalbumin-sensitized mutants

increased granulocyte number
- elevated at 3 weeks and increasing with age
- homozygotes display up to a 2-fold elevation in leukocyte numbers due to an increase in granulocytes

increased thymus weight
- increases with time and IBD

microcytic anemia

thymus hyperplasia
- increases with time and IBD

immune system phenotype

abnormal Langerhans cell physiology
- greater numbers of cells migrate to lymph nodes after hapten exposure

abnormal cytokine level

abnormal immune system physiology

abnormal interferon level
- IFNgamma is expressed in colon in mice with minor IBD symptoms
- elevated amounts of IFN gamma produced by irradiated CD4+ cells
- increased interferon gamma in the colon

abnormal interleukin level
- Il-2, but not Il-1beta is expressed in colon in mice with minor IBD symptoms
- increased IL 1 alpha, IL6, in the colon
- production of IL1 alpha is 3-4 times higher than controls 24 hours after LPS stimulation
- reduced IL4 production by irradiated CD4+ cells

abnormal leukocyte morphology

abnormal level of surface class II molecules

abnormal lymphocyte cell number
- double control levels in the lamina propria

abnormal myelopoiesis
- severely anemic homozygotes display a hyperproliferative myeloid compartment

abnormal response to infection
- upon infection with the nematode N. brasiliensis, homozygotes develop a Th1 response in addition to the expected nematode-induced Th2 response, as shown by a 5-fold increase in IFN-gamma levels in culture supernatants of Con A-stimulated spleen cells

abnormal tumor necrosis factor level
- TNFalpha is expressed in colon in mice with minor IBD symptoms
- increased TNF alpha in the colon
- production of TNF alpha is 3-4 times higher than controls 24 hours after LPS stimulation

abnormal type IV hypersensitivity reaction
- blockage of delayed-type hypertension by midrange UV radiation is prevented

cecum inflammation

chronic inflammation
- enterocolitis involving the entire intestinal tract, duodenum, proximal jejunum, and proximal colon
- inflammation was limited to the proximal colon under specific pathogen free conditions

colitis
- all Il10-null mice develop colitis by the age of 9 weeks in contrast to wild-type littermates

decreased T cell proliferation
- reduced proliferative response of CD4+ cells to UVB irradiation

decreased length of allograft survival
- significantly lower cardiac graft survival times

decreased spleen iron level

decreased spleen red pulp amount
- severely anemic homozygotes display hypoplasia of the splenic red pulp

immune system phenotype
- B and T lymphocytes develop normally
- at 4-6 weeks of age, young homozygotes exhibit normal CD4+ and CD8+ T subsets in thymus and spleen as well as normal B cell subsets in bone marrow, spleen and peritoneum relative to wild-type controls
- young homozygotes display normal antibody production and development of B cell memory in response to T cell-dependent immunization with haptenated chicken gamma-globulin
- young homozygotes show a normal antibody response to alpha (1-3)-dextrane, suggesting a normal B-1 cell subset in the peritoneum

increased CD4-positive, alpha beta T cell number
- activated memory phenotype
- elevated

increased IgE level
- total IgE levels are more than 7-fold higher and serum levels of OVA-specific IgE more than 2-fold higher than in wild-type mice after ovalbumin challenge

increased IgG1 level
- OVA-specific IgG1 levels are higher in ovalbumin-sensitized mutants

increased IgG2a level
- OVA-specific IgG2a levels are higher in ovalbumin-sensitized mutants

increased granulocyte number
- elevated at 3 weeks and increasing with age
- homozygotes display up to a 2-fold elevation in leukocyte numbers due to an increase in granulocytes

increased interferon-gamma secretion
- a similar increase in IFN-gamma production is found in cultures of anti-CD3-stimulated spleenic CD4+ T cells from nematode-infected homozygotes relative to infected controls
- upon infection with the nematode N. brasiliensis, homozygotes develop a Th1 response in addition to the expected nematode-induced Th2 response, as shown by a 5-fold increase in IFN-gamma levels in culture supernatants of Con A-stimulated spleen cells

increased susceptibility to parasitic infection
- in mice depleted of regulatory T cells, experimental cerebral malaria is delayed following exposure to Plasmodium falciparum but disease progression occurs unlike in wild-type mice similarly treated
- time to death induced by exposure to Plasmodium falciparum is decreased compared to in wild-type mice (7+/-0 days compared to 7.8+/-0.2 days, respectively)

increased susceptibility to type IV hypersensitivity reaction
- enhanced contact hypersensitivity to FITC

increased thymus weight
- increases with time and IBD

intestinal inflammation
- anemic and underweight homozygotes display enterocolitis involving the entire intestinal tract, duodenum, proximal jejunum, and proximal colon
- inflammation was limited to the proximal colon under specific pathogen free conditions
- spontaneous inflammatory bowel disease (IBD) develops by 5 weeks in some animals

large intestinal inflammation
- lymphocytes and small numbers of neutrophiles as infiltrates in the lamina propria of the cecum, ascending and transverse colon at three weeks
- more ulcerations at 6 months
- multifocal lesions in all regions of the large intestine at three months
- occasional transmural inflammation and crypt abscesses at 3 months

small intestinal inflammation
- 8% with duodenitis at 3 months of age
- increased duodenitis at 6 months

thymus hyperplasia
- increases with time and IBD

neoplasm

decreased incidence of tumors by UV induction
- do not develop skin tumors in response to UVB (280-350nm) exposure, even after 1 year

decreased tumor incidence
- CD8+ cells impart faster tumor rejection in hosts

increased intestinal adenocarcinoma incidence
- at 9 weeks, 13% of homozygotes have adenocarcinomas
- in 10-31 week old animals, there is a 65% incidence of colorectal carcinomas

increased large intestine adenocarcinoma incidence
- 25% with colorectal adenocarcinomas at 3 months
- higher incidence of colorectal cancer at 6 months but no metastasis to lymph nodes

respiratory system phenotype

decreased airway responsiveness
- airway response to methacholine is reduced by 37%
- less tension develops (restored by treatment with L-NAME)
- mutants are hyporesponsive to electrical field stimulation of trachea smooth muscle after OVA aerosol challenge
- mutants sensitized and challenged to ovalbumin (OVA) fail to develop airway hyper-responsiveness despite a significant eosinophilic airway inflammatory response
- tracheal rings are less responsive to KCl

homeostasis/metabolism phenotype

abnormal circulating enzyme level
- higher levels of alanine:2-oxaloglutarate aminotransferase in plasma 8 hours after lipopolysaccharide treatment

abnormal circulating protein level

abnormal circulating serum albumin level
- reduced

abnormal cytokine level

abnormal glucose homeostasis

abnormal homeostasis

abnormal interferon level
- IFNgamma is expressed in colon in mice with minor IBD symptoms
- elevated amounts of IFN gamma produced by irradiated CD4+ cells
- increased interferon gamma in the colon

abnormal interleukin level
- Il-2, but not Il-1beta is expressed in colon in mice with minor IBD symptoms
- increased IL 1 alpha, IL6, in the colon
- production of IL1 alpha is 3-4 times higher than controls 24 hours after LPS stimulation
- reduced IL4 production by irradiated CD4+ cells

abnormal iron level
- homozygotes display depleted iron stores in spleen and bone marrow

abnormal lipid level

abnormal nitric oxide homeostasis
- exhaled NO is significantly decreased

abnormal protein level
- increased phosphorylated protein kinase after insulin stimulation

abnormal tumor necrosis factor level
- TNFalpha is expressed in colon in mice with minor IBD symptoms
- increased TNF alpha in the colon
- production of TNF alpha is 3-4 times higher than controls 24 hours after LPS stimulation

decreased circulating cholesterol level
- decreased cholesterol esters

decreased circulating creatinine level

decreased circulating insulin level
- plasma insulin levels are 55% lower than controls after an overnight fast following 6 weeks on a high fat diet

decreased circulating iron level
- homozygotes display a 50% reduction in serum iron levels relative to wild-type controls

decreased physiological sensitivity to xenobiotic
- airway response to methacholine is reduced by 37%

decreased spleen iron level

enhanced wound healing
- by day 3, density of vascular structures significantly increased
- earlier and more persistent influx of greater numbers of macrophage into wound
- experimental wound is a 6 mm circular excision through the full thickness of the skin
- fully epithelialized and scab lost by 7 days
- increased collagen content and advanced maturation and organization of collagen bundles at 14 days
- macroscopic wound closure is accelerated

increased circulating cholesterol level
- increased free cholesterol

increased fatty acid level
- basal free fatty acid levels are significantly increased

increased insulin sensitivity
- greater increase in insulin stimulated whole body glucose uptake when corrected for lower plasma insulin

increased leukotriene level
- OVA-sensitized mutants exhibit higher eosinophil peroxidase and leukotriene levels in bronchoalveolar lavage fluid than wild-type mice

increased liver triglyceride level
- 54% increase in hepatic triglycerides relative to controls
- plasma triglycerides not elevated

increased myocardial infarction size
- 60% more polymorphonuclear neutrophiles per unit area in mid-ventricular slices relative to controls
- 90% more necrosis after experimental ischemia and reperfusion than found in controls

endocrine/exocrine gland phenotype

abnormal crypts of Lieberkuhn morphology

increased thymus weight
- increases with time and IBD

thymus hyperplasia
- increases with time and IBD

References

Kuhn R; Lohler J; Rennick D; Rajewsky K; Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis [see comments] Cell 75(2):263-74. PubMed: 8402911 MGI: J:15222

Additional References

Berg DJ; Davidson N; Kuhn R; Muller W; Menon S; Holland G; Thompson-Snipes L; Leach MW; Rennick D. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98(4):1010-20. PubMed: 8770874 MGI: J:35020
Bernert H; Sekikawa K; Radcliffe RA; Iraqi F; You M; Malkinson AM. 2003. Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: Gender-dependent modulation of IL-10 haploinsufficiency. Mol Carcinog 38(3):117-23. PubMed: 14587096 MGI: J:86489
Das G; Augustine MM; Das J; Bottomly K; Ray P; Ray A. 2003. An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci U S A 100(9):5324-9. PubMed: 12695566 MGI: J:83283
Dresner-Pollak R; Gelb N; Rachmilewitz D; Karmeli F; Weinreb M. 2004. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127(3):792-801. PubMed: 15362035 MGI: J:93577
Froicu M; Weaver V; Wynn TA; McDowell MA; Welsh JE; Cantorna MT. 2003. A crucial role for the vitamin d receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17(12):2386-92. PubMed: 14500760 MGI: J:86860
Hegazi RA; Mady HH; Melhem MF; Sepulveda AR; Mohi M; Kandil HM. 2003. Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice. Inflamm Bowel Dis 9(4):230-6. PubMed: 12902846 MGI: J:85702
Huang EH; Carter JJ; Whelan RL; Liu YH; Rosenberg JO; Rotterdam H; Schmidt AM; Stern DM; Forde KA. 2002. Colonoscopy in mice. Surg Endosc 16(1):22-4. PubMed: 11961598 MGI: J:77864
Justice JP; Shibata Y; Sur S; Mustafa J; Fan M; Van Scott MR. 2001. IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol 280(2):L363-8. PubMed: 11159016 MGI: J:68061
Lin T; Bost KL. 2004. STAT3 activation in macrophages following infection with Salmonella. Biochem Biophys Res Commun 321(4):828-34. PubMed: 15358102 MGI: J:91740
Mizoguchi A; Mizoguchi E; Takedatsu H; Blumberg RS; Bhan AK. 2002. Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation. Immunity 16(2):219-30. PubMed: 11869683 MGI: J:74718
Morrison AC; Wilson CB; Ray M; Correll PH. 2004. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol 172(3):1825-32. PubMed: 14734766 MGI: J:87661
Murphy ML; Wille U; Villegas EN; Hunter CA; Farrell JP. 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 31(10):2848-56. PubMed: 11592059 MGI: J:72355
O'Mahony L; Feeney M; O'Halloran S; Murphy L; Kiely B; Fitzgibbon J; Lee G; O'Sullivan G; Shanahan F; Collins JK. 2001. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15(8):1219-25. PubMed: 11472326 MGI: J:70926
Pimenta-Araujo R; Mascarell L; Huesca M; Cumano A; Bandeira A. 2002. Deoxyguanosine blocks allograft rejection of thymic epithelium but not lymphocyte infiltration and recognition. Eur J Immunol 32(1):77-86. PubMed: 11754006 MGI: J:73937
Rachmilewitz D; Karmeli F; Takabayashi K; Hayashi T; Leider-Trejo L; Lee J; Leoni LM; Raz E. 2002. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122(5):1428-41. PubMed: 11984528 MGI: J:76343
Teshima T; Reddy P; Lowler KP; KuKuruga MA; Liu C; Cooke KR; Ferrara JL. 2002. Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease. Blood 99(5):1825-32. PubMed: 11861301 MGI: J:75083
Wang Q; Fang CH; Hasselgren PO. 2001. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281(3):R1013-23. PubMed: 11507020 MGI: J:71507
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J. 2002. IL-10 regulates murine lupus. J Immunol 169(4):2148-55. PubMed: 12165544 MGI: J:78239

Additional - Il10^tm1Cgn related

Aggarwal NR; Tsushima K; Eto Y; Tripathi A; Mandke P; Mock JR; Garibaldi BT; Singer BD; Sidhaye VK; Horton MR; King LS; D'Alessio FR. 2014. Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation. J Immunol 192(9):4453-64. PubMed: 24688024 MGI: J:209966
Akane K; Kojima S; Mak TW; Shiku H; Suzuki H. 2016. CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity. Proc Natl Acad Sci U S A 113(9):2460-5. PubMed: 26869716 MGI: J:230413
Akhiani AA; Stensson A; Schon K; Lycke NY. 2005. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol 174(12):8144-53. PubMed: 15944323 MGI: J:100891
Alayan J; Ivanovski S; Farah CS. 2007. Alveolar bone loss in T helper 1/T helper 2 cytokine-deficient mice. J Periodontal Res 42(2):97-103. PubMed: 17305866 MGI: J:147935
Albert E; Walker J; Thiesen A; Churchill T; Madsen K. 2010. cis-Urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation. PLoS One 5(10):e13676. PubMed: 21060867 MGI: J:166665
Aliberti J; Viola JP; Vieira-de-Abreu A; Bozza PT; Sher A; Scharfstein J. 2003. Cutting edge: Bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J Immunol 170(11):5349-53. PubMed: 12759407 MGI: J:83453
Allen HL; Deepe GS Jr. 2006. B cells and CD4-CD8- T cells are key regulators of the severity of reactivation histoplasmosis. J Immunol 177(3):1763-71. PubMed: 16849486 MGI: J:138028
Allen HL; Deepe GS Jr. 2005. Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest 115(10):2875-85. PubMed: 16151533 MGI: J:101533
Almeida AR; Legrand N; Papiernik M; Freitas AA. 2002. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169(9):4850-60. PubMed: 12391195 MGI: J:125748
Amante FH; Stanley AC; Randall LM; Zhou Y; Haque A; McSweeney K; Waters AP; Janse CJ; Good MF; Hill GR; Engwerda CR. 2007. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol 171(2):548-59. PubMed: 17600128 MGI: J:123927
Ameredes BT; Sethi JM; Liu HL; Choi AM; Calhoun WJ. 2005. Enhanced nitric oxide production associated with airway hyporesponsiveness in the absence of IL-10. Am J Physiol Lung Cell Mol Physiol 288(5):L868-73. PubMed: 15618456 MGI: J:115459
Ameredes BT; Zamora R; Gibson KF; Billiar TR; Dixon-McCarthy B; Watkins S; Calhoun WJ. 2001. Increased nitric oxide production by airway cells of sensitized and challenged IL-10 knockout mice. J Leukoc Biol 70(5):730-6. PubMed: 11698492 MGI: J:124461
Ameredes BT; Zamora R; Sethi JM; Liu HL; Kohut LK; Gligonic AL; Choi AM; Calhoun WJ. 2005. Alterations in nitric oxide and cytokine production with airway inflammation in the absence of IL-10. J Immunol 175(2):1206-13. PubMed: 16002724 MGI: J:100726
Ananieva O; Darragh J; Johansen C; Carr JM; McIlrath J; Park JM; Wingate A; Monk CE; Toth R; Santos SG; Iversen L; Arthur JS. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 9(9):1028-36. PubMed: 18690222 MGI: J:139576
Anderson AC; Reddy J; Nazareno R; Sobel RA; Nicholson LB; Kuchroo VK. 2004. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J Immunol 173(2):828-34. PubMed: 15240669 MGI: J:91913
Anderson CF; Oukka M; Kuchroo VJ; Sacks D. 2007. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204(2):285-97. PubMed: 17283207 MGI: J:125372
Andou A; Hisamatsu T; Okamoto S; Chinen H; Kamada N; Kobayashi T; Hashimoto M; Okutsu T; Shimbo K; Takeda T; Matsumoto H; Sato A; Ohtsu H; Suzuki M; Hibi T. 2009. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 136(2):564-74.e2. PubMed: 19027739 MGI: J:145874
Andrade EB; Alves J; Madureira P; Oliveira L; Ribeiro A; Cordeiro-da-Silva A; Correia-Neves M; Trieu-Cuot P; Ferreira P. 2013. TLR2-induced IL-10 production impairs neutrophil recruitment to infected tissues during neonatal bacterial sepsis. J Immunol 191(9):4759-68. PubMed: 24078699 MGI: J:206234
Andrassy M; Igwe J; Autschbach F; Volz C; Remppis A; Neurath MF; Schleicher E; Humpert PM; Wendt T; Liliensiek B; Morcos M; Schiekofer S; Thiele K; Chen J; Kientsch-Engel R; Schmidt AM; Stremmel W; Stern DM; Katus HA; Nawroth PP; Bierhaus A. 2006. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol 169(4):1223-37. PubMed: 17003481 MGI: J:113376
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J. 2012. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene. Mol Immunol 51(2):143-9. PubMed: 22424785 MGI: J:184874
Apte RS; Richter J; Herndon J; Ferguson TA. 2006. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3(8):e310. PubMed: 16903779 MGI: J:134144
Arrieta MC; Madsen K; Doyle J; Meddings J. 2009. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 58(1):41-8. PubMed: 18829978 MGI: J:213262
Arsenescu R; Blum AM; Metwali A; Elliott DE; Weinstock JV. 2005. IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation. J Immunol 174(7):3906-11. PubMed: 15778345 MGI: J:110005
Auerbuch V; Isberg RR. 2007. Growth of Yersinia pseudotuberculosis in Mice Occurs Independently of Toll-Like Receptor 2 Expression and Induction of Interleukin-10. Infect Immun 75(7):3561-70. PubMed: 17420232 MGI: J:122417
Aviszus K; Macleod MK; Kirchenbaum GA; Detanico TO; Heiser RA; St Clair JB; Guo W; Wysocki LJ. 2012. Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells. J Immunol 189(9):4275-83. PubMed: 23008448 MGI: J:190617
Awasthi A; Carrier Y; Peron JP; Bettelli E; Kamanaka M; Flavell RA; Kuchroo VK; Oukka M; Weiner HL. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380-9. PubMed: 17994022 MGI: J:127774
Bai F; Town T; Qian F; Wang P; Kamanaka M; Connolly TM; Gate D; Montgomery RR; Flavell RA; Fikrig E. 2009. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog 5(10):e1000610. PubMed: 19816558 MGI: J:162907
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N. 2000. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes J Immunol 165(12):7330-7. PubMed: 11120869 MGI: J:66103
Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N. 2000. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell Immunol 202(2):97-102. PubMed: 10896769 MGI: J:114170
Bamboat ZM; Ocuin LM; Balachandran VP; Obaid H; Plitas G; Dematteo RP. 2010. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest 120(2):559-69. PubMed: 20093775 MGI: J:156672
Bandukwala HS; Clay BS; Tong J; Mody PD; Cannon JL; Shilling RA; Verbeek JS; Weinstock JV; Solway J; Sperling AI. 2007. Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med 204(8):1875-89. PubMed: 17664287 MGI: J:125951
Barbi J; Brombacher F; Satoskar AR. 2008. T Cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation. J Immunol 181(7):4613-20. PubMed: 18802063 MGI: J:141294
Bassaganya-Riera J; Viladomiu M; Pedragosa M; De Simone C; Hontecillas R. 2012. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 7(4):e34676. PubMed: 22511958 MGI: J:187088
Beatty PL; Plevy SE; Sepulveda AR; Finn OJ. 2007. Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. J Immunol 179(2):735-9. PubMed: 17617560 MGI: J:149347
Beckwith J; Cong Y; Sundberg JP; Elson CO; Leiter EH. 2005. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 129(5):1473-84. PubMed: 16285949 MGI: J:101721
Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD. 2001. Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans. Infect Immun 69(10):6445-55. PubMed: 11553589 MGI: J:71570
Beissert S; Hosoi J; Kuhn R; Rajewsky K; Muller W; Granstein RD. 1996. Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice. J Invest Dermatol 107(4):553-7. PubMed: 8823360 MGI: J:35510
Beiting DP; Bliss SK; Schlafer DH; Roberts VL; Appleton JA. 2004. Interleukin-10 limits local and body cavity inflammation during infection with muscle-stage Trichinella spiralis. Infect Immun 72(6):3129-37. PubMed: 15155614 MGI: J:90250
Belkaid Y; Hoffmann KF; Mendez S; Kamhawi S; Udey MC; Wynn TA; Sacks DL. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194(10):1497-506. PubMed: 11714756 MGI: J:118003
Benakis C; Brea D; Caballero S; Faraco G; Moore J; Murphy M; Sita G; Racchumi G; Ling L; Pamer EG; Iadecola C; Anrather J. 2016. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med 22(5):516-23. PubMed: 27019327 MGI: J:234857
Berg DJ; Davidson N; Kuhn R; Muller W; Menon S; Holland G; Thompson-Snipes L; Leach MW; Rennick D. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98(4):1010-20. PubMed: 8770874 MGI: J:35020
Berg DJ; Leach MW; Kuhn R; Rajewsky K; Muller W; Davidson NJ; Rennick D. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182(1):99-108. PubMed: 7790826 MGI: J:26221
Bernert H; Sekikawa K; Radcliffe RA; Iraqi F; You M; Malkinson AM. 2003. Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: Gender-dependent modulation of IL-10 haploinsufficiency. Mol Carcinog 38(3):117-23. PubMed: 14587096 MGI: J:86489
Bettelli E; Das MP; Howard ED; Weiner HL; Sobel RA; Kuchroo VK. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161(7):3299-306. PubMed: 9759845 MGI: J:115204
Bettenworth D; Buyse M; Bohm M; Mennigen R; Czorniak I; Kannengiesser K; Brzoska T; Luger TA; Kucharzik T; Domschke W; Maaser C; Lugering A. 2011. The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function. Am J Pathol 179(3):1230-42. PubMed: 21741932 MGI: J:176323
Bhattacharyya S; Deb J; Patra AK; Thuy Pham DA; Chen W; Vaeth M; Berberich-Siebelt F; Klein-Hessling S; Lamperti ED; Reifenberg K; Jellusova J; Schweizer A; Nitschke L; Leich E; Rosenwald A; Brunner C; Engelmann S; Bommhardt U; Avots A; Muller MR; Kondo E; Serfling E. 2011. NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network. J Exp Med 208(4):823-39. PubMed: 21464221 MGI: J:177319
Biburger M; Tiegs G. 2008. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. J Leukoc Biol 84(1):264-79. PubMed: 18407967 MGI: J:137749
Biswas A; Wilmanski J; Forsman H; Hrncir T; Hao L; Tlaskalova-Hogenova H; Kobayashi KS. 2011. Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur J Immunol 41(1):182-94. PubMed: 21182089 MGI: J:174655
Bleich A; Buchler G; Beckwith J; Petell LM; Affourtit JP; King BL; Shaffer DJ; Roopenian DC; Hedrich HJ; Sundberg JP; Leiter EH. 2010. Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity. Inflamm Bowel Dis 16(5):765-75. PubMed: 19856416 MGI: J:171733
Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mahler M; Hedrich HJ; Fichtner-Feigl S; Scholmerich J; Falk W; Hofmann C; Obermeier F. 2009. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology 136(1):278-87. PubMed: 18952084 MGI: J:145618
Bliss SK; Alcaraz A; Appleton JA. 2003. IL-10 prevents liver necrosis during murine infection with Trichinella spiralis. J Immunol 171(6):3142-7. PubMed: 12960341 MGI: J:85372
Bliss SK; Bliss SP; Beiting DP; Alcaraz A; Appleton JA. 2007. IL-10 regulates movement of intestinally derived CD4+ T cells to the liver. J Immunol 178(12):7974-83. PubMed: 17548634 MGI: J:148582
Blois SM; Ilarregui JM; Tometten M; Garcia M; Orsal AS; Cordo-Russo R; Toscano MA; Bianco GA; Kobelt P; Handjiski B; Tirado I; Markert UR; Klapp BF; Poirier F; Szekeres-Bartho J; Rabinovich GA; Arck PC. 2007. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13(12):1450-7. PubMed: 18026113 MGI: J:130208
Blum A; Setiawan T; Hang L; Stoyanoff K; Weinstock JV. 2008. Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation. Infect Immun 76(8):3651-6. PubMed: 18505813 MGI: J:139373
Bollyky PL; Falk BA; Long SA; Preisinger A; Braun KR; Wu RP; Evanko SP; Buckner JH; Wight TN; Nepom GT. 2009. CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J Immunol 183(4):2232-41. PubMed: 19635906 MGI: J:151479
Bollyky PL; Wu RP; Falk BA; Lord JD; Long SA; Preisinger A; Teng B; Holt GE; Standifer NE; Braun KR; Xie CF; Samuels PL; Vernon RB; Gebe JA; Wight TN; Nepom GT. 2011. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci U S A 108(19):7938-43. PubMed: 21518860 MGI: J:172198
Bosmann M; Haggadone MD; Zetoune FS; Sarma JV; Ward PA. 2013. The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation. Eur J Immunol 43(7):1907-13. PubMed: 23575697 MGI: J:201024
Bosschaerts T; Guilliams M; Noel W; Herin M; Burk RF; Hill KE; Brys L; Raes G; Ghassabeh GH; De Baetselier P; Beschin A. 2008. Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J Immunol 180(9):6168-75. PubMed: 18424738 MGI: J:134536
Bowie RV; Donatello S; Lyes C; Owens MB; Babina IS; Hudson L; Walsh SV; O'Donoghue DP; Amu S; Barry SP; Fallon PG; Hopkins AM. 2012. Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 302(8):G781-93. PubMed: 22241861 MGI: J:185388
Brewer S; McPherson M; Fujiwara D; Turovskaya O; Ziring D; Chen L; Takedatsu H; Targan SR; Wei B; Braun J. 2008. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography. Gastroenterology 135(3):744-55. PubMed: 18639553 MGI: J:142005
Bristol IJ; Farmer MA; Cong Y; Zheng XX; Strom TB; Elson CO; Sundberg JP; Leiter EH. 2000. Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm Bowel Dis 6(4):290-302. PubMed: 11149562 MGI: J:109882
Brooks DG; Trifilo MJ; Edelmann KH; Teyton L; McGavern DB; Oldstone MB. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12(11):1301-9. PubMed: 17041596 MGI: J:115332
Brooks DG; Walsh KB; Elsaesser H; Oldstone MB. 2010. IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Proc Natl Acad Sci U S A 107(7):3018-23. PubMed: 20133700 MGI: J:157557
Browne EP. 2013. Toll-Like Receptor 7 Inhibits Early Acute Retroviral Infection through Rapid Lymphocyte Responses. J Virol 87(13):7357-66. PubMed: 23616654 MGI: J:198442
Brunn A; Mihelcic M; Carstov M; Hummel L; Geier F; Schmidt A; Saupe L; Utermohlen O; Deckert M. 2014. IL-10, IL-4, and STAT6 promote an M2 milieu required for termination of P0(106-125)-induced murine experimental autoimmune neuritis. Am J Pathol 184(10):2627-40. PubMed: 25108223 MGI: J:214835
Bundoc VG; Keane-Myers A. 2007. IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis. Exp Eye Res 85(4):575-9. PubMed: 17765892 MGI: J:126367
Bunt SK; Clements VK; Hanson EM; Sinha P; Ostrand-Rosenberg S. 2009. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J Leukoc Biol 85(6):996-1004. PubMed: 19261929 MGI: J:149766
Burich A; Hershberg R; Waggie K; Zeng W; Brabb T; Westrich G; Viney JL; Maggio-Price L. 2001. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 281(3):G764-78. PubMed: 11518689 MGI: J:108283
Buxbaum LU; Scott P. 2005. Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infect Immun 73(4):2101-8. PubMed: 15784551 MGI: J:97206
Cain JA; Smith JA; Ondr JK; Wang B; Katz JD. 2006. NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J Immunol 176(3):1645-54. PubMed: 16424194 MGI: J:126603
Caligiuri G; Rudling M; Ollivier V; Jacob MP; Michel JB; Hansson GK; Nicoletti A. 2003. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 9(1-2):10-7. PubMed: 12765335 MGI: J:105858
Cantorna MT; Munsick C; Bemiss C; Mahon BD. 2000. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease J Nutr 130(11):2648-52. PubMed: 11053501 MGI: J:65513
Cao AT; Yao S; Stefka AT; Liu Z; Qin H; Liu H; Evans-Marin HL; Elson CO; Nagler CR; Cong Y. 2014. TLR4 regulates IFN-gamma and IL-17 production by both thymic and induced Foxp3+ Tregs during intestinal inflammation. J Leukoc Biol 96(5):895-905. PubMed: 25015957 MGI: J:220139
Carregaro V; Valenzuela JG; Cunha TM; Verri WA Jr; Grespan R; Matsumura G; Ribeiro JM; Elnaiem DE; Silva JS; Cunha FQ. 2008. Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway. J Leukoc Biol 84(1):104-14. PubMed: 18390928 MGI: J:137750
Carrero JA; Calderon B; Unanue ER. 2006. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med 203(4):933-40. PubMed: 16549598 MGI: J:123753
Carroll IM; Andrus JM; Bruno-Barcena JM; Klaenhammer TR; Hassan HM; Threadgill DS. 2007. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293(4):G729-38. PubMed: 17640978 MGI: J:126666
Cascio JA; Haymaker CL; Divekar RD; Zaghouani S; Khairallah MT; Wan X; Rowland LM; Dhakal M; Chen W; Zaghouani H. 2013. Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance. J Immunol 190(12):6004-14. PubMed: 23686493 MGI: J:204839
Cassani B; Villablanca EJ; Quintana FJ; Love PE; Lacy-Hulbert A; Blaner WS; Sparwasser T; Snapper SB; Weiner HL; Mora JR. 2011. Gut-tropic T cells that express integrin alpha4beta7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology 141(6):2109-18. PubMed: 21925467 MGI: J:180414
Castano AP; Lin SL; Surowy T; Nowlin BT; Turlapati SA; Patel T; Singh A; Li S; Lupher ML Jr; Duffield JS. 2009. Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 1(5):5ra13. PubMed: 20368175 MGI: J:167887
Cedeno-Laurent F; Opperman M; Barthel SR; Kuchroo VK; Dimitroff CJ. 2012. Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J Immunol 188(7):3127-37. PubMed: 22345665 MGI: J:183114
Chacon-Salinas R; Limon-Flores AY; Chavez-Blanco AD; Gonzalez-Estrada A; Ullrich SE. 2011. Mast cell-derived IL-10 suppresses germinal center formation by affecting T follicular helper cell function. J Immunol 186(1):25-31. PubMed: 21098222 MGI: J:168010
Chang EY; Guo B; Doyle SE; Cheng G. 2007. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 178(11):6705-9. PubMed: 17513714 MGI: J:147854
Chang J; Kunkel SL; Chang CH. 2009. Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci U S A 106(43):18327-32. PubMed: 19815506 MGI: J:153746
Chang J; Voorhees TJ; Liu Y; Zhao Y; Chang CH. 2010. Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A. Proc Natl Acad Sci U S A 107(18):8340-5. PubMed: 20404153 MGI: J:160329
Charoenlap N; Shen Z; McBee ME; Muthupalani S; Wogan GN; Fox JG; Schauer DB. 2012. Alkyl hydroperoxide reductase is required for Helicobacter cinaedi intestinal colonization and survival under oxidative stress in BALB/c and BALB/c interleukin-10-/- mice. Infect Immun 80(3):921-8. PubMed: 22184416 MGI: J:182450
Chassaing B; Koren O; Goodrich JK; Poole AC; Srinivasan S; Ley RE; Gewirtz AT. 2015. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519(7541):92-6. PubMed: 25731162 MGI: J:219843
Chassaing B; Ley RE; Gewirtz AT. 2014. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology 147(6):1363-77.e17. PubMed: 25172014 MGI: J:229155
Chelvarajan L; Popa D; Liu Y; Getchell TV; Stromberg AJ; Bondada S. 2007. Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages. J Leukoc Biol 82(2):403-16. PubMed: 17495050 MGI: J:123516
Chen F; Liu Z; Wu W; Rozo C; Bowdridge S; Millman A; Van Rooijen N; Urban JF Jr; Wynn TA; Gause WC. 2012. An essential role for T(H)2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med 18(2):260-6. PubMed: 22245779 MGI: J:181182
Chen HQ; Shen TY; Zhou YK; Zhang M; Chu ZX; Hang XM; Qin HL. 2010. Lactobacillus plantarum Consumption Increases PepT1-Mediated Amino Acid Absorption by Enhancing Protein Kinase C Activity in Spontaneously Colitic Mice. J Nutr 140(12):2201-6. PubMed: 20980636 MGI: J:166148
Chen W; Shu D; Chadwick VS. 2001. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J Gastroenterol Hepatol 16(4):377-83. PubMed: 11354274 MGI: J:103513
Chen X; Duan XS; Xu LJ; Zhao JJ; She ZF; Chen WW; Zheng ZJ; Jiang GD. 2014. Interleukin-10 mediates the neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice. Neuroscience 266:235-43. PubMed: 24291771 MGI: J:210354
Chiaramonte MG; Hesse M; Cheever AW; Wynn TA. 2000. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J Immunol 164(2):973-85. PubMed: 10623847 MGI: J:127058
Chiaramonte MG; Mentink-Kane M; Jacobson BA; Cheever AW; Whitters MJ; Goad ME; Wong A; Collins M; Donaldson DD; Grusby MJ; Wynn TA. 2003. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197(6):687-701. PubMed: 12642601 MGI: J:124413
Chmiel JF; Konstan MW; Saadane A; Krenicky JE; Lester Kirchner H; Berger M. 2002. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am J Respir Crit Care Med 165(8):1176-81. PubMed: 11956064 MGI: J:103028
Chow A; Lucas D; Hidalgo A; Mendez-Ferrer S; Hashimoto D; Scheiermann C; Battista M; Leboeuf M; Prophete C; van Rooijen N; Tanaka M; Merad M; Frenette PS. 2011. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 208(2):261-71. PubMed: 21282381 MGI: J:176846
Chung Y; Zhang N; Wooten RM. 2013. Borrelia burgdorferi elicited-IL-10 suppresses the production of inflammatory mediators, phagocytosis, and expression of co-stimulatory receptors by murine macrophages and/or dendritic cells. PLoS One 8(12):e84980. PubMed: 24367705 MGI: J:225170
Clark K; MacKenzie KF; Petkevicius K; Kristariyanto Y; Zhang J; Choi HG; Peggie M; Plater L; Pedrioli PG; McIver E; Gray NS; Arthur JS; Cohen P. 2012. Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages. Proc Natl Acad Sci U S A 109(42):16986-91. PubMed: 23033494 MGI: J:190393
Clemente-Casares X; Blanco J; Ambalavanan P; Yamanouchi J; Singha S; Fandos C; Tsai S; Wang J; Garabatos N; Izquierdo C; Agrawal S; Keough MB; Yong VW; James E; Moore A; Yang Y; Stratmann T; Serra P; Santamaria P. 2016. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530(7591):434-40. PubMed: 26886799 MGI: J:229667
Clementi AH; Gaudy AM; van Rooijen N; Pierce RH; Mooney RA. 2009. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta 1792(11):1062-72. PubMed: 19699298 MGI: J:164851
Clemons KV; Grunig G; Sobel RA; Mirels LF; Rennick DM; Stevens DA. 2000. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis Clin Exp Immunol 122(2):186-91. PubMed: 11091273 MGI: J:65686
Cohen SJ; Cohen IR; Nussbaum G. 2010. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice. J Immunol 184(1):212-21. PubMed: 19949074 MGI: J:159039
Collison LW; Pillai MR; Chaturvedi V; Vignali DA. 2009. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 182(10):6121-8. PubMed: 19414764 MGI: J:150297
Corsetti PP; de Almeida LA; Carvalho NB; Azevedo V; Silva TM; Teixeira HC; Faria AC; Oliveira SC. 2013. Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice. PLoS One 8(9):e74729. PubMed: 24069337 MGI: J:207535
Crow AR; Song S; Semple JW; Freedman J; Lazarus AH. 2007. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood 109(1):155-8. PubMed: 16954498 MGI: J:142178
Cuff S; Dolton G; Matthews RJ; Gallimore A. 2010. Antigen specificity determines the pro- or antitumoral nature of CD8+ T cells. J Immunol 184(2):607-14. PubMed: 20007540 MGI: J:159412
Cyktor JC; Carruthers B; Beamer GL; Turner J. 2013. Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. PLoS One 8(3):e58612. PubMed: 23472214 MGI: J:199388
Czarneski J; Lin YC; Chong S; McCarthy B; Fernandes H; Parker G; Mansour A; Huppi K; Marti GE; Raveche E. 2004. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia 18(3):597-606. PubMed: 14712288 MGI: J:88136
D'Alessio FR; Tsushima K; Aggarwal NR; West EE; Willett MH; Britos MF; Pipeling MR; Brower RG; Tuder RM; McDyer JF; King LS. 2009. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119(10):2898-913. PubMed: 19770521 MGI: J:154630
D'Alessio S; Correale C; Tacconi C; Gandelli A; Pietrogrande G; Vetrano S; Genua M; Arena V; Spinelli A; Peyrin-Biroulet L; Fiocchi C; Danese S. 2014. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest 124(9):3863-78. PubMed: 25105363 MGI: J:215745
D'Orazio TJ; Niederkorn JY. 1998. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 160(5):2089-98. PubMed: 9498745 MGI: J:111362
Dai H; Wan N; Zhang S; Moore Y; Wan F; Dai Z. 2010. Cutting edge: Programmed Death-1 defines CD8+ CD122+ T cells as regulatory versus memory T cells. J Immunol 185(2):803-7. PubMed: 20548035 MGI: J:161937
Dai WJ; Kohler G; Brombacher F. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol 158(5):2259-67. PubMed: 9036973 MGI: J:110855
Dann SM; Le C; Choudhury BK; Liu H; Saldarriaga O; Hanson EM; Cong Y; Eckmann L. 2014. Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium. Infect Immun 82(5):1949-58. PubMed: 24566625 MGI: J:209888
Darling AR; Freyschmidt EJ; Burton OT; Koleoglou KJ; Oyoshi MK; Oettgen HC. 2014. IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum. Clin Immunol 150(2):153-60. PubMed: 24412909 MGI: J:209389
Darragh J; Ananieva O; Courtney A; Elcombe S; Arthur JS. 2010. MSK1 regulates the transcription of IL-1ra in response to TLR activation in macrophages. Biochem J 425(3):595-602. PubMed: 19922413 MGI: J:159202
Das G; Augustine MM; Das J; Bottomly K; Ray P; Ray A. 2003. An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci U S A 100(9):5324-9. PubMed: 12695566 MGI: J:83283
Davidson NJ; Fort MM; Muller W; Leach MW; Rennick DM. 2000. Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response Int Rev Immunol 19(1):91-121. PubMed: 10723680 MGI: J:61253
Davidson NJ; Leach MW; Fort MM; Thompson-Snipes L; Kuhn R; Muller W; Berg DJ; Rennick DM. 1996. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184(1):241-51. PubMed: 8691138 MGI: J:34035
Davies PS; Powell AE; Swain JR; Wong MH. 2009. Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One 4(8):e6530. PubMed: 19657387 MGI: J:152479
De Fazio SR; Gozzo JJ. 2000. Role of graft interleukin-10 expression in the tolerogenicity of neonatal skin allografts Transplantation 70(9):1371-7. PubMed: 11087155 MGI: J:65782
Deepe GS Jr; Buesing WR. 2012. Deciphering the pathways of death of Histoplasma capsulatum-infected macrophages: implications for the immunopathogenesis of early infection. J Immunol 188(1):334-44. PubMed: 22102723 MGI: J:180361
Deepe GS Jr; Gibbons RS. 2003. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10. J Immunol 171(10):5353-62. PubMed: 14607938 MGI: J:117988
Del Sero G; Mencacci A; Cenci E; d'Ostiani CF; Montagnoli C; Bacci A; Mosci P; Kopf M; Romani L. 1999. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect 1(14):1169-80. PubMed: 10580272 MGI: J:106542
Demangel C; Bertolino P; Britton WJ. 2002. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol 32(4):994-1002. PubMed: 11920565 MGI: J:75998
Demols A; Van Laethem JL; Quertinmont E; Degraef C; Delhaye M; Geerts A; Deviere J. 2002. Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 282(6):G1105-12. PubMed: 12016137 MGI: J:108286
Deng B; Wehling-Henricks M; Villalta SA; Wang Y; Tidball JG. 2012. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol 189(7):3669-80. PubMed: 22933625 MGI: J:190351
Deng J; Yuan S; Pennati A; Murphy J; Wu JH; Lawson D; Galipeau J. 2014. Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response. Cancer Res 74(15):4133-44. PubMed: 24938765 MGI: J:213719
Denning TL; Wang YC; Patel SR; Williams IR; Pulendran B. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8(10):1086-94. PubMed: 17873879 MGI: J:125258
Dennis KL; Wang Y; Blatner NR; Wang S; Saadalla A; Trudeau E; Roers A; Weaver CT; Lee JJ; Gilbert JA; Chang EB; Khazaie K. 2013. Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res 73(19):5905-13. PubMed: 23955389 MGI: J:202608
Dercamp C; Chemin K; Caux C; Trinchieri G; Vicari AP. 2005. Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses. Cancer Res 65(18):8479-86. PubMed: 16166328 MGI: J:101610
Di Marco R; Xiang M; Zaccone P; Leonardi C; Franco S; Meroni P; Nicoletti F. 1999. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency Autoimmunity 31(2):75-83. PubMed: 10680745 MGI: J:60463
DiFedele LM; He J; Bonkowski EL; Han X; Held MA; Bohan A; Menon RK; Denson LA. 2005. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology 128(5):1278-91. PubMed: 15887111 MGI: J:124938
Dieleman LA; Arends A; Tonkonogy SL; Goerres MS; Craft DW; Grenther W; Sellon RK; Balish E; Sartor RB. 2000. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun 68(9):5107-13. PubMed: 10948132 MGI: J:64076
Dresner-Pollak R; Gelb N; Rachmilewitz D; Karmeli F; Weinreb M. 2004. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127(3):792-801. PubMed: 15362035 MGI: J:93577
Dube PE; Yan F; Punit S; Girish N; McElroy SJ; Washington MK; Polk DB. 2012. Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest 122(8):2780-92. PubMed: 22772467 MGI: J:190076
Dubois B; Chapat L; Goubier A; Papiernik M; Nicolas JF; Kaiserlian D. 2003. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 102(9):3295-301. PubMed: 12855551 MGI: J:115675
Duell BL; Carey AJ; Tan CK; Cui X; Webb RI; Totsika M; Schembri MA; Derrington P; Irving-Rodgers H; Brooks AJ; Cripps AW; Crowley M; Ulett GC. 2012. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J Immunol 188(2):781-92. PubMed: 22184725 MGI: J:180771
Dutta A; Huang CT; Chen TC; Lin CY; Chiu CH; Lin YC; Chang CS; He YC. 2015. IL-10 inhibits neuraminidase-activated TGF-beta and facilitates Th1 phenotype during early phase of infection. Nat Commun 6:6374. PubMed: 25728041 MGI: J:221784
Eaton KA; Mefford M; Thevenot T. 2001. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 166(12):7456-61. PubMed: 11390498 MGI: J:124425
Eckmann L; Nebelsiek T; Fingerle AA; Dann SM; Mages J; Lang R; Robine S; Kagnoff MF; Schmid RM; Karin M; Arkan MC; Greten FR. 2008. Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc Natl Acad Sci U S A 105(39):15058-63. PubMed: 18815378 MGI: J:143368
Edmunds SJ; Roy NC; Love DR; Laing WA. 2011. Kiwifruit extracts inhibit cytokine production by lipopolysaccharide-activated macrophages, and intestinal epithelial cells isolated from IL10 gene deficient mice. Cell Immunol 270(1):70-9. PubMed: 21600571 MGI: J:176754
El Kasmi KC; Holst J; Coffre M; Mielke L; de Pauw A; Lhocine N; Smith AM; Rutschman R; Kaushal D; Shen Y; Suda T; Donnelly RP; Myers MG Jr; Alexander W; Vignali DA; Watowich SS; Ernst M; Hilton DJ; Murray PJ. 2006. General nature of the STAT3-activated anti-inflammatory response. J Immunol 177(11):7880-8. PubMed: 17114459 MGI: J:140695
El Kasmi KC; Smith AM; Williams L; Neale G; Panopolous A; Watowich SS; Hacker H; Foxwell BM; Murray PJ. 2007. Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 179(11):7215-9. PubMed: 18025162 MGI: J:133009
Elcombe SE; Naqvi S; Van Den Bosch MW; MacKenzie KF; Cianfanelli F; Brown GD; Arthur JS. 2013. Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markers. PLoS One 8(3):e60086. PubMed: 23533666 MGI: J:199902
Ellermann M; Huh EY; Liu B; Carroll IM; Tamayo R; Sartor RB. 2015. Adherent-Invasive Escherichia coli Production of Cellulose Influences Iron-Induced Bacterial Aggregation, Phagocytosis, and Induction of Colitis. Infect Immun 83(10):4068-80. PubMed: 26216423 MGI: J:233109
Elliott DE; Setiawan T; Metwali A; Blum A; Urban JF Jr; Weinstock JV. 2004. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 34(10):2690. PubMed: 15368285 MGI: J:92338
Eming SA; Werner S; Bugnon P; Wickenhauser C; Siewe L; Utermohlen O; Davidson JM; Krieg T; Roers A. 2007. Accelerated wound closure in mice deficient for interleukin-10. Am J Pathol 170(1):188-202. PubMed: 17200193 MGI: J:117053
Endharti AT; Rifa'I M st; Shi Z; Fukuoka Y; Nakahara Y; Kawamoto Y; Takeda K; Isobe K; Suzuki H. 2005. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175(11):7093-7. PubMed: 16301610 MGI: J:122202
Ermann J; Garrett WS; Kuchroo J; Rourida K; Glickman JN; Bleich A; Glimcher LH. 2011. Severity of innate immune-mediated colitis is controlled by the cytokine deficiency-induced colitis susceptibility-1 (Cdcs1) locus. Proc Natl Acad Sci U S A 108(17):7137-41. PubMed: 21482794 MGI: J:171340
Ertelt JM; Buyukbasaran EZ; Jiang TT; Rowe JH; Xin L; Way SS. 2013. B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells. J Leukoc Biol 94(2):367-76. PubMed: 23744647 MGI: J:204423
Fang Y; Sharp GC; Braley-Mullen H. 2008. Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol 172(6):1591-602. PubMed: 18467701 MGI: J:136188
Farmer MA; Sundberg JP; Bristol IJ; Churchill GA; Li R; Elson CO; Leiter EH. 2001. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A 98(24):13820-5. PubMed: 11707574 MGI: J:72978
Fasnacht N; Greweling MC; Bollati-Fogolin M; Schippers A; Muller W. 2009. T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection. Eur J Immunol 39(8):2173-83. PubMed: 19593768 MGI: J:151695
Fassbender M; Gerlitzki B; Ullrich N; Lupp C; Klein M; Radsak MP; Schmitt E; Bopp T; Schild H. 2010. Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation. Cell Immunol 265(2):91-6. PubMed: 20728078 MGI: J:165335
Feng D; Wang Y; Xu Y; Luo Q; Lan B; Xu L. 2009. Interleukin 10 deficiency exacerbates halothane induced liver injury by increasing interleukin 8 expression and neutrophil infiltration. Biochem Pharmacol 77(2):277-84. PubMed: 18940183 MGI: J:144654
Feng P; Chai J; Zhou M; Simon N; Huang L; Wang H. 2014. Interleukin-10 is produced by a specific subset of taste receptor cells and critical for maintaining structural integrity of mouse taste buds. J Neurosci 34(7):2689-701. PubMed: 24523558 MGI: J:206936
Fillatreau S; Sweenie CH; McGeachy MJ; Gray D; Anderton SM. 2002. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3(10):944-50. PubMed: 12244307 MGI: J:79219
Fitzgerald DC; Zhang GX; El-Behi M; Fonseca-Kelly Z; Li H; Yu S; Saris CJ; Gran B; Ciric B; Rostami A. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8(12):1372-9. PubMed: 17994023 MGI: J:127773
Flanagan K; Modrusan Z; Cornelius J; Chavali A; Kasman I; Komuves L; Mo L; Diehl L. 2008. Intestinal Epithelial Cell Up-Regulation of LY6 Molecules during Colitis Results in Enhanced Chemokine Secretion. J Immunol 180(6):3874-81. PubMed: 18322195 MGI: J:133031
Flano E; Kayhan B; Woodland DL; Blackman MA. 2005. Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation. J Immunol 175(5):3225-34. PubMed: 16116213 MGI: J:113212
Florek M; Sega EI; Leveson-Gower DB; Baker J; Muller AM; Schneidawind D; Meyer E; Negrin RS. 2014. Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. Blood 124(11):1832-42. PubMed: 25030062 MGI: J:214627
Foulds KE; Rotte MJ; Seder RA. 2006. IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection. J Immunol 177(4):2565-74. PubMed: 16888018 MGI: J:138354
Frazier WJ; Wang X; Wancket LM; Li XA; Meng X; Nelin LD; Cato AC; Liu Y. 2009. Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice. J Immunol 183(11):7411-9. PubMed: 19890037 MGI: J:157403
Freitas do Rosario AP; Lamb T; Spence P; Stephens R; Lang A; Roers A; Muller W; O'Garra A; Langhorne J. 2012. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol 188(3):1178-90. PubMed: 22205023 MGI: J:180758
French AR; Sjolin H; Kim S; Koka R; Yang L; Young DA; Cerboni C; Tomasello E; Ma A; Vivier E; Karre K; Yokoyama WM. 2006. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol 177(8):4981-90. PubMed: 17015680 MGI: J:139300
Freyschmidt-Paul P; McElwee KJ; Happle R; Kissling S; Wenzel E; Sundberg JP; Zoller M; Hoffmann R. 2002. Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol 119(4):980-2. PubMed: 12406350 MGI: J:80138
Froicu M; Weaver V; Wynn TA; McDowell MA; Welsh JE; Cantorna MT. 2003. A crucial role for the vitamin d receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17(12):2386-92. PubMed: 14500760 MGI: J:86860
Froicu M; Zhu Y; Cantorna MT. 2006. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 117(3):310-8. PubMed: 16476050 MGI: J:107077
Fujiwara H; Yamazaki T; Uzawa A; Nagata K; Kobayashi Y. 2008. Transient infiltration of neutrophils into the thymus following whole-body X-ray irradiation in IL-10 knockout mice. Biochem Biophys Res Commun 369(2):432-6. PubMed: 18291100 MGI: J:134174
Gabrysova L; Nicolson KS; Streeter HB; Verhagen J; Sabatos-Peyton CA; Morgan DJ; Wraith DC. 2009. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med 206(8):1755-67. PubMed: 19635862 MGI: J:151484
Gaddi PJ; Crane MJ; Kamanaka M; Flavell RA; Yap GS; Salazar-Mather TP. 2012. IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection. PLoS One 7(8):e42850. PubMed: 22880122 MGI: J:189817
Gao Y; Herndon JM; Zhang H; Griffith TS; Ferguson TA. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med 188(5):887-96. PubMed: 9730890 MGI: J:112021
Garikipati VN; Krishnamurthy P; Verma SK; Khan M; Abramova T; Mackie AR; Qin G; Benedict C; Nickoloff E; Johnson J; Gao E; Losordo DW; Houser SR; Koch WJ; Kishore R. 2015. Negative Regulation of miR-375 by Interleukin-10 Enhances Bone Marrow-Derived Progenitor Cell-Mediated Myocardial Repair and Function After Myocardial Infarction. Stem Cells 33(12):3519-29. PubMed: 26235810 MGI: J:228825
Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kuhn R; Muller W; Trinchieri G; Sher A. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157(2):798-805. PubMed: 8752931 MGI: J:34041
Genovese T; Esposito E; Mazzon E; Di Paola R; Caminiti R; Bramanti P; Cappelani A; Cuzzocrea S. 2009. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem 108(6):1360-72. PubMed: 19183262 MGI: J:146854
Getahun A; Smith MJ; Kogut I; van Dyk LF; Cambier JC. 2012. Retention of anergy and inhibition of antibody responses during acute gamma herpesvirus 68 infection. J Immunol 189(6):2965-74. PubMed: 22904300 MGI: J:189918
Getts DR; Turley DM; Smith CE; Harp CT; McCarthy D; Feeney EM; Getts MT; Martin AJ; Luo X; Terry RL; King NJ; Miller SD. 2011. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J Immunol 187(5):2405-17. PubMed: 21821796 MGI: J:179266
Giachini FR; Zemse SM; Carneiro FS; Lima VV; Carneiro ZN; Callera GE; Ergul A; Webb RC; Tostes RC. 2009. Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. Am J Physiol Heart Circ Physiol 296(2):H489-96. PubMed: 19074677 MGI: J:146372
Gjertsson I; Hultgren OH; Tarkowski A. 2002. Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol 130(3):409-14. PubMed: 12452830 MGI: J:131892
Gonnella PA; Waldner HP; Kodali D; Weiner HL. 2004. Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis. J Autoimmun 23(3):193-200. PubMed: 15501390 MGI: J:93230
Gonzalez A; Andre-Schmutz I; Carnaud C; Mathis D; Benoist C. 2001. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nat Immunol 2(12):1117-25. PubMed: 11713466 MGI: J:109860
Gonzalez-Navajas JM; Fine S; Law J; Datta SK; Nguyen KP; Yu M; Corr M; Katakura K; Eckman L; Lee J; Raz E. 2010. TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J Clin Invest 120(2):570-81. PubMed: 20051628 MGI: J:156686
Gotoh K; Inoue M; Masaki T; Chiba S; Shimasaki T; Ando H; Fujiwara K; Katsuragi I; Kakuma T; Seike M; Sakata T; Yoshimatsu H. 2012. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced hypothalamic inflammation. J Neurochem 120(5):752-64. PubMed: 22146087 MGI: J:182778
Gotoh K; Inoue M; Masaki T; Chiba S; Shimasaki T; Ando H; Fujiwara K; Katsuragi I; Kakuma T; Seike M; Sakata T; Yoshimatsu H. 2012. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes 61(8):1994-2003. PubMed: 22648387 MGI: J:208454
Gourdy P; Schambourg A; Filipe C; Douin-Echinard V; Garmy-Susini B; Calippe B; Terce F; Bayard F; Arnal JF. 2007. Transforming growth factor activity is a key determinant for the effect of estradiol on fatty streak deposit in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 27(10):2214-21. PubMed: 17690314 MGI: J:134877
Grilli M; Barbieri I; Basudev H; Brusa R; Casati C; Lozza G; Ongini E. 2000. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 12(7):2265-72. PubMed: 10947805 MGI: J:108086
Grimbaldeston MA; Nakae S; Kalesnikoff J; Tsai M; Galli SJ. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8(10):1095-104. PubMed: 17767162 MGI: J:125267
Gross O; Yazdi AS; Thomas CJ; Masin M; Heinz LX; Guarda G; Quadroni M; Drexler SK; Tschopp J. 2012. Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36(3):388-400. PubMed: 22444631 MGI: J:187333
Grunig G; Corry DB; Leach MW; Seymour BW; Kurup VP; Rennick DM. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185(6):1089-99. PubMed: 9091582 MGI: J:39230
Gu Y; Yang J; Ouyang X; Liu W; Li H; Yang J; Bromberg J; Chen SH; Mayer L; Unkeless JC; Xiong H. 2008. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 38(7):1807-13. PubMed: 18506885 MGI: J:137290
Guarda G; Braun M; Staehli F; Tardivel A; Mattmann C; Forster I; Farlik M; Decker T; Du Pasquier RA; Romero P; Tschopp J. 2011. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34(2):213-23. PubMed: 21349431 MGI: J:168972
Gudmundsson G; Bosch A; Davidson BL; Berg DJ; Hunninghake GW. 1998. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol 19(5):812-8. PubMed: 9806746 MGI: J:114214
Guerrero A; Fries BC. 2008. Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response. Infect Immun 76(9):4322-31. PubMed: 18591227 MGI: J:138887
Guilbault C; Stotland P; Lachance C; Tam M; Keller A; Thompson-Snipes L; Cowley E; Hamilton TA; Eidelman DH; Stevenson MM; Radzioch D. 2002. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 107(3):297-305. PubMed: 12423305 MGI: J:113617
Guilliams M; Movahedi K; Bosschaerts T; VandenDriessche T; Chuah MK; Herin M; Acosta-Sanchez A; Ma L; Moser M; Van Ginderachter JA; Brys L; De Baetselier P; Beschin A. 2009. IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J Immunol 182(2):1107-18. PubMed: 19124754 MGI: J:143483
Guilliams M; Oldenhove G; Noel W; Herin M; Brys L; Loi P; Flamand V; Moser M; De Baetselier P; Beschin A. 2007. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J Immunol 179(5):2748-57. PubMed: 17709488 MGI: J:151836
Guillot-Sestier MV; Doty KR; Gate D; Rodriguez J Jr; Leung BP; Rezai-Zadeh K; Town T. 2015. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85(3):534-48. PubMed: 25619654 MGI: J:219701
Guindi C; Menard M; Cloutier A; Gaudreau S; Besin G; Larivee P; McDonald PP; Dupuis G; Amrani A. 2012. Differential role of NF-kappaB, ERK1/2 and AP-1 in modulating the immunoregulatory functions of bone marrow-derived dendritic cells from NOD mice. Cell Immunol 272(2):259-68. PubMed: 22070873 MGI: J:181379
Gulbransen BD; Bashashati M; Hirota SA; Gui X; Roberts JA; MacDonald JA; Muruve DA; McKay DM; Beck PL; Mawe GM; Thompson RJ; Sharkey KA. 2012. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med 18(4):600-4. PubMed: 22426419 MGI: J:183386
Gunnett CA; Berg DJ; Faraci FM; Feuerstein G. 1999. Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke 30(10):2191-5; discussion 2195-6. PubMed: 10512928 MGI: J:59742
Gunnett CA; Heistad DD; Berg DJ; Faraci FM. 2000. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation Am J Physiol Heart Circ Physiol 279(4):H1555-62. PubMed: 11009441 MGI: J:65225
Gunnett CA; Lund DD; Faraci FM; Heistad DD. 2005. Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction. Am J Physiol Heart Circ Physiol 289(2):H624-30. PubMed: 16014616 MGI: J:100322
Guo Z; Wen Z; Qin A; Zhou Y; Liao Z; Liu Z; Liang Y; Ren T; Xu L. 2013. Antisense Oligonucleotide Treatment Enhances the Recovery of Acute Lung Injury through IL-10-Secreting M2-like Macrophage-Induced Expansion of CD4+ Regulatory T Cells. J Immunol 190(8):4337-48. PubMed: 23514739 MGI: J:195286
Haag LM; Fischer A; Otto B; Plickert R; Kuhl AA; Gobel UB; Bereswill S; Heimesaat MM. 2012. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. PLoS One 7(7):e40761. PubMed: 22808254 MGI: J:189623
Haggqvist B; Hultman P. 2005. Interleukin-10 in murine metal-induced systemic autoimmunity. Clin Exp Immunol 141(3):422-31. PubMed: 16045731 MGI: J:100639
Hale LP; Greer PK. 2012. A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features. PLoS One 7(7):e41797. PubMed: 22848611 MGI: J:189696
Hale LP; Perera D; Gottfried MR; Maggio-Price L; Srinivasan S; Marchuk D. 2007. Neonatal co-infection with helicobacter species markedly accelerates the development of inflammation-associated colonic neoplasia in IL-10(-/-) mice. Helicobacter 12(6):598-604. PubMed: 18001399 MGI: J:141450
Hall AO; Beiting DP; Tato C; John B; Oldenhove G; Lombana CG; Pritchard GH; Silver JS; Bouladoux N; Stumhofer JS; Harris TH; Grainger J; Wojno ED; Wagage S; Roos DS; Scott P; Turka LA; Cherry S; Reiner SL; Cua D; Belkaid Y; Elloso MM; Hunter CA. 2012. The Cytokines Interleukin 27 and Interferon-gamma Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology. Immunity 37(3):511-23. PubMed: 22981537 MGI: J:187660
Hamano S; Asgharpour A; Stroup SE; Wynn TA; Leiter EH; Houpt E. 2006. Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production. J Immunol 177(2):1208-13. PubMed: 16818779 MGI: J:134990
Hammer M; Mages J; Dietrich H; Schmitz F; Striebel F; Murray PJ; Wagner H; Lang R. 2005. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur J Immunol 35(10):2991-3001. PubMed: 16184516 MGI: J:113501
Hammer M; Mages J; Dietrich H; Servatius A; Howells N; Cato AC; Lang R. 2006. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 203(1):15-20. PubMed: 16380512 MGI: J:118833
Hao S; Yuan J; Xu S; Munegowda MA; Deng Y; Gordon J; Xing Z; Xiang J. 2008. Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexes. J Immunol 181(4):2428-37. PubMed: 18684933 MGI: J:140189
Harrington LE; Hatton RD; Mangan PR; Turner H; Murphy TL; Murphy KM; Weaver CT. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11):1123-32. PubMed: 16200070 MGI: J:112601
Harris BS; Fairfield HE; Ward-Bailey PF; Bronson RT; Reinholdt LG; Bergstrom DE. 2017. Shaky all over: a recessive mutation on Chromosome 13 MGI Direct Data Submission :. MGI: J:237902
Hasegawa E; Oshima Y; Takeda A; Saeki K; Yoshida H; Sonoda KH; Ishibashi T. 2012. IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn. J Leukoc Biol 91(2):267-73. PubMed: 22045869 MGI: J:181046
Hasko G; Szabo C; Nemeth ZH; Salzman AL; Vizi ES. 1998. Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent. Eur J Immunol 28(2):468-72. PubMed: 9521054 MGI: J:46196
Hata H; Sakaguchi N; Yoshitomi H; Iwakura Y; Sekikawa K; Azuma Y; Kanai C; Moriizumi E; Nomura T; Nakamura T; Sakaguchi S. 2004. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582-8. PubMed: 15314695 MGI: J:92002
Hayasaka D; Shirai K; Aoki K; Nagata N; Simantini DS; Kitaura K; Takamatsu Y; Gould E; Suzuki R; Morita K. 2013. TNF-alpha acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection. PLoS One 8(8):e71643. PubMed: 23940775 MGI: J:204932
Hegazi RA; Mady HH; Melhem MF; Sepulveda AR; Mohi M; Kandil HM. 2003. Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice. Inflamm Bowel Dis 9(4):230-6. PubMed: 12902846 MGI: J:85702
Hegazi RA; Rao KN; Mayle A; Sepulveda AR; Otterbein LE; Plevy SE. 2005. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 202(12):1703-13. PubMed: 16365149 MGI: J:118826
Heidegger S; Kirchner SK; Stephan N; Bohn B; Suhartha N; Hotz C; Anz D; Sandholzer N; Stecher B; Russmann H; Endres S; Bourquin C. 2013. TLR activation excludes circulating naive CD8+ T cells from gut-associated lymphoid organs in mice. J Immunol 190(10):5313-20. PubMed: 23589622 MGI: J:202547
Helmby H; Grencis RK. 2003. Contrasting roles for IL-10 in protective immunity to different life cycle stages of intestinal nematode parasites. Eur J Immunol 33(9):2382-90. PubMed: 12938214 MGI: J:85455
Hernandez Y; Arora S; Erb-Downward JR; McDonald RA; Toews GB; Huffnagle GB. 2005. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 174(2):1027-36. PubMed: 15634927 MGI: J:95831
Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167(11):6533-44. PubMed: 11714822 MGI: J:72822
Hickey MJ; Issekutz AC; Reinhardt PH; Fedorak RN; Kubes P. 1998. Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res 83(11):1124-31. PubMed: 9831707 MGI: J:114199
Hill EV; Ng TH; Burton BR; Oakley CM; Malik K; Wraith DC. 2015. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol 45(4):1103-15. PubMed: 25627813 MGI: J:229272
Hirotani T; Lee PY; Kuwata H; Yamamoto M; Matsumoto M; Kawase I; Akira S; Takeda K. 2005. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 174(6):3650-7. PubMed: 15749903 MGI: J:97704
Hoentjen F; Sartor RB; Ozaki M; Jobin C. 2005. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105(2):689-96. PubMed: 15251981 MGI: J:96516
Hoffmann KF; Cheever AW; Wynn TA. 2000. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164(12):6406-16. PubMed: 10843696 MGI: J:124519
Hoffmann KF; James SL; Cheever AW; Wynn TA. 1999. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 163(2):927-38. PubMed: 10395689 MGI: J:56157
Horikawa M; Weimer ET; DiLillo DJ; Venturi GM; Spolski R; Leonard WJ; Heise MT; Tedder TF. 2013. Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J Immunol 190(3):1158-68. PubMed: 23275601 MGI: J:193035
Hsu AC; Scott P. 2007. Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation. J Immunol 179(12):8200-7. PubMed: 18056363 MGI: J:155036
Hu S; Ciancio MJ; Lahav M; Fujiya M; Lichtenstein L; Anant S; Musch MW; Chang EB. 2007. Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammation. Gastroenterology 133(6):1893-904. PubMed: 18054561 MGI: J:135619
Huang EH; Park JC; Appelman H; Weinberg AD; Banerjee M; Logsdon CD; Schmidt AM. 2006. Induction of inflammatory bowel disease accelerates adenoma formation in Min +/- mice. Surgery 139(6):782-8. PubMed: 16782435 MGI: J:115828
Huang G; Wang Y; Shi LZ; Kanneganti TD; Chi H. 2011. Signaling by the Phosphatase MKP-1 in Dendritic Cells Imprints Distinct Effector and Regulatory T Cell Fates. Immunity 35(1):45-58. PubMed: 21723158 MGI: J:174378
Huang H; Ostroff GR; Lee CK; Wang JP; Specht CA; Levitz SM. 2009. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect Immun 77(5):1774-81. PubMed: 19273561 MGI: J:148181
Hung CY; Castro-Lopez N; Cole GT. 2014. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10. Infect Immun 82(2):903-13. PubMed: 24478103 MGI: J:209804
Hunter CA; Ellis-Neyes LA; Slifer T; Kanaly S; Grunig G; Fort M; Rennick D; Araujo FG. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 158(7):3311-6. PubMed: 9120288 MGI: J:110835
Igietseme JU; Ananaba GA; Bolier J; Bowers S; Moore T; Belay T; Eko FO; Lyn D; Black CM. 2000. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol 164(8):4212-9. PubMed: 10754317 MGI: J:123433
Ilarregui JM; Croci DO; Bianco GA; Toscano MA; Salatino M; Vermeulen ME; Geffner JR; Rabinovich GA. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 10(9):981-91. PubMed: 19668220 MGI: J:151758
Inoue S; Leitner WW; Golding B; Scott D. 2006. Inhibitory effects of B cells on antitumor immunity. Cancer Res 66(15):7741-7. PubMed: 16885377 MGI: J:112103
Ismail HF; Fick P; Zhang J; Lynch RG; Berg DJ. 2003. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 170(7):3782-9. PubMed: 12646644 MGI: J:125444
Ismail HF; Zhang J; Lynch RG; Wang Y; Berg DJ. 2003. Role for complement in development of Helicobacter-induced gastritis in interleukin-10-deficient mice. Infect Immun 71(12):7140-8. PubMed: 14638805 MGI: J:86649
Ivanov SS; Roy CR. 2013. Pathogen signatures activate a ubiquitination pathway that modulates the function of the metabolic checkpoint kinase mTOR. Nat Immunol 14(12):1219-28. PubMed: 24121838 MGI: J:208652
Ivory CP; Wallace LE; McCafferty DM; Sigalet DL. 2008. Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 295(6):G1202-10. PubMed: 18845573 MGI: J:143407
Jain N; Khullar B; Oswal N; Banoth B; Joshi P; Ravindran B; Panda S; Basak S; George A; Rath S; Bal V; Sopory S. 2016. TLR-mediated albuminuria needs TNFalpha-mediated co-operativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues. Dis Model Mech :. PubMed: 27125280 MGI: J:232565
Jakobshagen K; Ward B; Baschuk N; Huss S; Brunn A; Malecki M; Fiolka M; Rappl G; Corogeanu D; Karow U; Schiller P; Abken H; Heukamp LC; Deckert M; Kronke M; Utermohlen O. 2015. Endogenous Il10 Alleviates the Systemic Antiviral Cellular Immune Response and T Cell-Mediated Immunopathology in Select Organs of Acutely LCMV-Infected Mice. Am J Pathol 185(11):3025-38. PubMed: 26506472 MGI: J:227259
Jamontt J; Petit S; Clark N; Parkinson SJ; Smith P. 2013. Nucleotide-Binding Oligomerization Domain 2 Signaling Promotes Hyperresponsive Macrophages and Colitis in IL-10-Deficient Mice. J Immunol 190(6):2948-58. PubMed: 23396949 MGI: J:193595
Jankovic D; Kullberg MC; Feng CG; Goldszmid RS; Collazo CM; Wilson M; Wynn TA; Kamanaka M; Flavell RA; Sher A. 2007. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204(2):273-83. PubMed: 17283209 MGI: J:125371
Jankovic D; Kullberg MC; Hieny S; Caspar P; Collazo CM; Sher A. 2002. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity 16(3):429-39. PubMed: 11911827 MGI: J:113516
Jeon SG; Kayama H; Ueda Y; Takahashi T; Asahara T; Tsuji H; Tsuji NM; Kiyono H; Ma JS; Kusu T; Okumura R; Hara H; Yoshida H; Yamamoto M; Nomoto K; Takeda K. 2012. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 8(5):e1002714. PubMed: 22693446 MGI: J:195381
Jeyarajah DR; Kielar ML; Saboorian H; Karimi P; Frantz N; Lu CY. 2006. Impact of bile duct obstruction on hepatic E. coli infection: role of IL-10. Am J Physiol Gastrointest Liver Physiol 291(1):G91-4. PubMed: 16769814 MGI: J:111075
Jimenez Mdel P; Walls L; Fierer J. 2006. High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression. Infect Immun 74(6):3387-95. PubMed: 16714569 MGI: J:109235
Jin Y; Liu R; Xie J; Xiong H; He JC; Chen N. 2013. Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab Invest 93(7):801-11. PubMed: 23628901 MGI: J:198752
Joffre O; Santolaria T; Calise D; Al Saati T; Hudrisier D; Romagnoli P; van Meerwijk JP. 2008. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14(1):88-92. PubMed: 18066074 MGI: J:130486
Johansson AC; Hansson AS; Nandakumar KS; Backlund J; Holmdahl R. 2001. Il-10-deficient b10.q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type ii collagen antibodies. J Immunol 167(6):3505-12. PubMed: 11544344 MGI: J:71518
Joller N; Lozano E; Burkett PR; Patel B; Xiao S; Zhu C; Xia J; Tan TG; Sefik E; Yajnik V; Sharpe AH; Quintana FJ; Mathis D; Benoist C; Hafler DA; Kuchroo VK. 2014. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40(4):569-81. PubMed: 24745333 MGI: J:209951
Jones DE; Ackermann MR; Wille U; Hunter CA; Scott P. 2002. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun 70(4):2151-8. PubMed: 11895981 MGI: J:75483
Jones SP; Trocha SD; Lefer DJ. 2001. Cardioprotective actions of endogenous IL-10 are independent of iNOS. Am J Physiol Heart Circ Physiol 281(1):H48-52. PubMed: 11406467 MGI: J:70292
Jones TG; Finkelman FD; Austen KF; Gurish MF. 2010. T regulatory cells control antigen-induced recruitment of mast cell progenitors to the lungs of C57BL/6 mice. J Immunol 185(3):1804-11. PubMed: 20601599 MGI: J:162451
Joo YE; Karrasch T; Muhlbauer M; Allard B; Narula A; Herfarth HH; Jobin C. 2009. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One 4(2):e4562. PubMed: 19234608 MGI: J:146226
Ju Z; Chavan SS; Antoine DJ; Dancho M; Tsaava T; Li J; Lu B; Levine YA; Stiegler A; Tamari Y; Al-Abed Y; Roth J; Tracey KJ; Yang H. 2014. Sequestering HMGB1 via DNA-conjugated beads ameliorates murine colitis. PLoS One 9(8):e103992. PubMed: 25127031 MGI: J:223145
Jung YJ; Ryan L; LaCourse R; North RJ. 2003. Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology 109(2):295-9. PubMed: 12757625 MGI: J:83724
Jurisic G; Sundberg JP; Bleich A; Leiter EH; Broman KW; Buechler G; Alley L; Vestweber D; Detmar M. 2010. Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease. Genes Immun 11(3):219-31. PubMed: 20220769 MGI: J:159522
Justice JP; Shibata Y; Sur S; Mustafa J; Fan M; Van Scott MR. 2001. IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol 280(2):L363-8. PubMed: 11159016 MGI: J:68061
Kabbur PM; Carson WF 4th; Guernsey L; Secor ER Jr; Thrall RS; Schramm CM. 2006. Interleukin-10 does not mediate inhalational tolerance in a chronic model of ovalbumin-induced allergic airway disease. Cell Immunol 239(1):67-74. PubMed: 16765924 MGI: J:110165
Kadayakkara DK; Ranganathan S; Young WB; Ahrens ET. 2012. Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI. Lab Invest 92(4):636-45. PubMed: 22330343 MGI: J:181905
Kaiser F; Cook D; Papoutsopoulou S; Rajsbaum R; Wu X; Yang HT; Grant S; Ricciardi-Castagnoli P; Tsichlis PN; Ley SC; O'Garra A. 2009. TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells. J Exp Med 206(9):1863-71. PubMed: 19667062 MGI: J:152170
Kalkunte SS; Neubeck S; Norris WE; Cheng SB; Kostadinov S; Vu Hoang D; Ahmed A; von Eggeling F; Shaikh Z; Padbury J; Berg G; Olofsson A; Markert UR; Sharma S. 2013. Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model. Am J Pathol 183(5):1425-36. PubMed: 24035612 MGI: J:202475
Kamada N; Hisamatsu T; Okamoto S; Sato T; Matsuoka K; Arai K; Nakai T; Hasegawa A; Inoue N; Watanabe N; Akagawa KS; Hibi T. 2005. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 175(10):6900-8. PubMed: 16272349 MGI: J:119692
Kamanaka M; Huber S; Zenewicz LA; Gagliani N; Rathinam C; O'Connor W Jr; Wan YY; Nakae S; Iwakura Y; Hao L; Flavell RA. 2011. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J Exp Med 208(5):1027-40. PubMed: 21518800 MGI: J:177300
Kanazawa Y; Saito Y; Supriatna Y; Tezuka H; Kotani T; Murata Y; Okazawa H; Ohnishi H; Kinouchi Y; Nojima Y; Ohteki T; Shimosegawa T; Matozaki T. 2010. Role of SIRPalpha in regulation of mucosal immunity in the intestine. Genes Cells 15(12):1189-200. PubMed: 21040253 MGI: J:186324
Kane MM; Mosser DM. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166(2):1141-7. PubMed: 11145695 MGI: J:66849
Kapp JA; Honjo K; Kapp LM; Xu X; Cozier A; Bucy RP. 2006. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int Immunol 18(11):1549-62. PubMed: 16966495 MGI: J:114951
Karrasch T; Kim JS; Jang BI; Jobin C. 2007. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS One 2(7):e596. PubMed: 17611628 MGI: J:129302
Karrasch T; Kim JS; Muhlbauer M; Magness ST; Jobin C. 2007. Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol 178(10):6522-32. PubMed: 17475882 MGI: J:146107
Kashi VP; Ortega SB; Karandikar NJ. 2014. Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function. PLoS One 9(8):e105763. PubMed: 25144738 MGI: J:221089
Kastenmuller W; Gasteiger G; Subramanian N; Sparwasser T; Busch DH; Belkaid Y; Drexler I; Germain RN. 2011. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol 187(6):3186-97. PubMed: 21849683 MGI: J:179230
Kato A; Okaya T; Lentsch AB. 2003. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury. Hepatology 37(2):304-12. PubMed: 12540780 MGI: J:105813
Kawachi S; Jennings S; Panes J; Cockrell A; Laroux FS; Gray L; Perry M; van der Heyde H; Balish E; Granger DN; Specian RA; Grisham MB. 2000. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. Am J Physiol Gastrointest Liver Physiol 278(5):G734-43. PubMed: 10801266 MGI: J:108662
Kearley J; Barker JE; Robinson DS; Lloyd CM. 2005. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202(11):1539-47. PubMed: 16314435 MGI: J:118855
Kellermann SA; McEvoy LM. 2001. The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J Immunol 167(2):682-90. PubMed: 11441071 MGI: J:120507
Kelly J; Ali Khan A; Yin J; Ferguson TA; Apte RS. 2007. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 117(11):3421-6. PubMed: 17975672 MGI: J:127374
Khan AR; Hams E; Floudas A; Sparwasser T; Weaver CT; Fallon PG. 2015. PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun 6:5997. PubMed: 25609381 MGI: J:219708
Kim H; Keum DJ; Kwak Jw; Chung HS; Bae H. 2014. Bee venom phospholipase A2 protects against acetaminophen-induced acute liver injury by modulating regulatory T cells and IL-10 in mice. PLoS One 9(12):e114726. PubMed: 25478691 MGI: J:225681
Kim SC; Tonkonogy SL; Albright CA; Tsang J; Balish EJ; Braun J; Huycke MM; Sartor RB. 2005. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128(4):891-906. PubMed: 15825073 MGI: J:97309
Kimura T; Sugaya M; Blauvelt A; Okochi H; Sato S. 2013. Delayed wound healing due to increased interleukin-10 expression in mice with lymphatic dysfunction. J Leukoc Biol 94(1):137-45. PubMed: 23650621 MGI: J:201849
Kinnebrew MA; Buffie CG; Diehl GE; Zenewicz LA; Leiner I; Hohl TM; Flavell RA; Littman DR; Pamer EG. 2012. Interleukin 23 Production by Intestinal CD103(+)CD11b(+) Dendritic Cells in Response to Bacterial Flagellin Enhances Mucosal Innate Immune Defense. Immunity 36(2):276-87. PubMed: 22306017 MGI: J:181332
Kish L; Hotte N; Kaplan GG; Vincent R; Tso R; Ganzle M; Rioux KP; Thiesen A; Barkema HW; Wine E; Madsen KL. 2013. Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One 8(4):e62220. PubMed: 23638009 MGI: J:200552
Kitamura H; Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Matsumura K; Takeda Y; Uza N; Nagata K; Chiba T. 2011. Role of heat shock protein 47 in intestinal fibrosis of experimental colitis. Biochem Biophys Res Commun 404(2):599-604. PubMed: 21144841 MGI: J:168792
Kobayashi T; Steinbach EC; Russo SM; Matsuoka K; Nochi T; Maharshak N; Borst LB; Hostager B; Garcia-Martinez JV; Rothman PB; Kashiwada M; Sheikh SZ; Murray PJ; Plevy SE. 2014. NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis. J Immunol 192(4):1918-27. PubMed: 24442434 MGI: J:209365
Kontoyiannis D; Kotlyarov A; Carballo E; Alexopoulou L; Blackshear PJ; Gaestel M; Davis R; Flavell R; Kollias G. 2001. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 20(14):3760-70. PubMed: 11447117 MGI: J:108402
Kosiewicz MM; Alard P; Liang S; Clark SL. 2004. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand. Int Immunol 16(5):697-706. PubMed: 15096489 MGI: J:89454
Kowalski GM; Nicholls HT; Risis S; Watson NK; Kanellakis P; Bruce CR; Bobik A; Lancaster GI; Febbraio MA. 2011. Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice. Diabetologia :. PubMed: 21210076 MGI: J:168585
Kraus TA; Brimnes J; Muong C; Liu JH; Moran TM; Tappenden KA; Boros P; Mayer L. 2005. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest 115(8):2234-2243. PubMed: 16041410 MGI: J:100225
Krishnamurthy P; Lambers E; Verma S; Thorne T; Qin G; Losordo DW; Kishore R. 2010. Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J 24(7):2484-94. PubMed: 20219984 MGI: J:162353
Krishnamurthy P; Thal M; Verma S; Hoxha E; Lambers E; Ramirez V; Qin G; Losordo D; Kishore R. 2011. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res 109(11):1280-9. PubMed: 21959218 MGI: J:188819
Kryczek I; Wei S; Zou L; Zhu G; Mottram P; Xu H; Chen L; Zou W. 2006. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 177(1):40-4. PubMed: 16785496 MGI: J:134411
Krzyszton CP; Sparkman NL; Grant RW; Buchanan JB; Broussard SR; Woods J; Johnson RW. 2008. Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation. Am J Physiol Regul Integr Comp Physiol 295(4):R1109-14. PubMed: 18650318 MGI: J:139972
Kulcsar KA; Baxter VK; Greene IP; Griffin DE. 2014. Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis. Proc Natl Acad Sci U S A 111(45):16053-8. PubMed: 25362048 MGI: J:216759
Kuo SM; Merhige PM; Hagey LR. 2013. The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10-/- mice. PLoS One 8(3):e60270. PubMed: 23555939 MGI: J:199881
Kurakevich E; Hennet T; Hausmann M; Rogler G; Borsig L. 2013. Milk oligosaccharide sialyl(alpha2,3)lactose activates intestinal CD11c+ cells through TLR4. Proc Natl Acad Sci U S A 110(43):17444-9. PubMed: 24101501 MGI: J:201973
Kurkjian C; Hollifield M; Lines JL; Rogosky A; Empey KM; Qureshi M; Brown SA; Garvy BA. 2012. Alveolar Macrophages in Neonatal Mice Are Inherently Unresponsive to Pneumocystis murina Infection. Infect Immun 80(8):2835-46. PubMed: 22665378 MGI: J:186637
Kuwata H; Watanabe Y; Miyoshi H; Yamamoto M; Kaisho T; Takeda K; Akira S. 2003. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102(12):4123-9. PubMed: 12907458 MGI: J:86681
Laidlaw BJ; Cui W; Amezquita RA; Gray SM; Guan T; Lu Y; Kobayashi Y; Flavell RA; Kleinstein SH; Craft J; Kaech SM. 2015. Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells. Nat Immunol 16(8):871-9. PubMed: 26147684 MGI: J:233057
Lampropoulou V; Hoehlig K; Roch T; Neves P; Gomez EC; Sweenie CH; Hao Y; Freitas AA; Steinhoff U; Anderton SM; Fillatreau S. 2008. TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity. J Immunol 180(7):4763-73. PubMed: 18354200 MGI: J:133381
Larson D; Hubner MP; Torrero MN; Morris CP; Brankin A; Swierczewski BE; Davies SJ; Vonakis BM; Mitre E. 2012. Chronic helminth infection reduces basophil responsiveness in an IL-10-dependent manner. J Immunol 188(9):4188-99. PubMed: 22461700 MGI: J:188452
Lathrop SK; Bloom SM; Rao SM; Nutsch K; Lio CW; Santacruz N; Peterson DA; Stappenbeck TS; Hsieh CS. 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478(7368):250-4. PubMed: 21937990 MGI: J:177128
Lazarus JJ; Kay MA; McCarter AL; Wooten RM. 2008. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun 76(3):1153-62. PubMed: 18086805 MGI: J:131640
Lazarus JJ; Meadows MJ; Lintner RE; Wooten RM. 2006. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 177(10):7076-85. PubMed: 17082624 MGI: J:140484
Lee CC; Kung JT. 2012. Marginal zone B cell is a major source of Il-10 in Listeria monocytogenes susceptibility. J Immunol 189(7):3319-27. PubMed: 22933629 MGI: J:190348
Lee CG; Homer RJ; Cohn L; Link H; Jung S; Craft JE; Graham BS; Johnson TR; Elias JA. 2002. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 277(38):35466-74. PubMed: 12107190 MGI: J:79116
Lee CW; Rao VP; Rogers AB; Ge Z; Erdman SE; Whary MT; Fox JG. 2007. Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun 75(6):2699-707. PubMed: 17353283 MGI: J:121929
Lee JH; Lee GT; Woo SH; Ha YS; Kwon SJ; Kim WJ; Kim IY. 2013. BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages. Cancer Res 73(12):3604-14. PubMed: 23633487 MGI: J:199016
Lee JJ; Rothenberg ME; Seeley ES; Zimdahl B; Kawano S; Lu WJ; Shin K; Sakata-Kato T; Chen JK; Diehn M; Clarke MF; Beachy PA. 2016. Control of inflammation by stromal Hedgehog pathway activation restrains colitis. Proc Natl Acad Sci U S A 113(47):E7545-E7553. PubMed: 27815529 MGI: J:238842
Lenzen H; Lunnemann M; Bleich A; Manns MP; Seidler U; Jorns A. 2012. Downregulation of the NHE3-binding PDZ-adaptor protein PDZK1 expression during cytokine-induced inflammation in interleukin-10-deficient mice. PLoS One 7(7):e40657. PubMed: 22848392 MGI: J:189711
Leveson-Gower DB; Sega EI; Kalesnikoff J; Florek M; Pan Y; Pierini A; Galli SJ; Negrin RS. 2013. Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells. Blood 122(22):3659-65. PubMed: 24030387 MGI: J:204074
Li B; Alli R; Vogel P; Geiger TL. 2014. IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis. Mucosal Immunol 7(4):869-78. PubMed: 24301657 MGI: J:234754
Li B; Gurung P; Malireddi RK; Vogel P; Kanneganti TD; Geiger TL. 2015. IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T-cell-mediated colitis. Nat Commun 6:6131. PubMed: 25607885 MGI: J:219712
Li C; Corraliza I; Langhorne J. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun 67(9):4435-42. PubMed: 10456884 MGI: J:57118
Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS. 2010. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Mol Immunol 47(15):2467-74. PubMed: 20615550 MGI: J:163936
Lin KL; Fulton LM; Berginski M; West ML; Taylor NA; Moran TP; Coghill JM; Blazar BR; Bear JE; Serody JS. 2014. Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD. Blood 123(10):1604-14. PubMed: 24415540 MGI: J:209503
Lippert E; Karrasch T; Sun X; Allard B; Herfarth HH; Threadgill D; Jobin C. 2009. Gnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS One 4(10):e7413. PubMed: 19841748 MGI: J:154043
Liu CY; Dube PE; Girish N; Reddy AT; Polk DB. 2015. Optical reconstruction of murine colorectal mucosa at cellular resolution. Am J Physiol Gastrointest Liver Physiol 308(9):G721-35. PubMed: 25721303 MGI: J:224167
Liu Y; Bi X; Xu S; Xiang J. 2005. Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses. Cancer Res 65(11):4955-62. PubMed: 15930318 MGI: J:98765
Liu Z; Falo LD Jr; You Z. 2011. Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity. J Immunol 187(1):118-25. PubMed: 21642542 MGI: J:176186
Liu Z; Liu JQ; Talebian F; Wu LC; Li S; Bai XF. 2013. IL-27 enhances the survival of tumor antigen-specific CD8(+) T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol 43(2):468-79. PubMed: 23225163 MGI: J:193049
Liva SM; Voskuhl RR. 2001. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 167(4):2060-7. PubMed: 11489988 MGI: J:120413
London A; Itskovich E; Benhar I; Kalchenko V; Mack M; Jung S; Schwartz M. 2011. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J Exp Med 208(1):23-39. PubMed: 21220455 MGI: J:176855
Londono D; Marques A; Hornung RL; Cadavid D. 2008. IL-10 helps control pathogen load during high-level bacteremia. J Immunol 181(3):2076-83. PubMed: 18641346 MGI: J:139233
Londono D; Marques A; Hornung RL; Cadavid D. 2008. Relapsing fever borreliosis in interleukin-10-deficient mice. Infect Immun 76(12):5508-13. PubMed: 18794280 MGI: J:142597
Loser K; Apelt J; Voskort M; Mohaupt M; Balkow S; Schwarz T; Grabbe S; Beissert S. 2007. IL-10 controls ultraviolet-induced carcinogenesis in mice. J Immunol 179(1):365-71. PubMed: 17579057 MGI: J:125760
Louis H; Van Laethem JL; Wu W; Quertinmont E; Degraef C; Van den Berg K; Demols A; Goldman M; Le Moine O; Geerts A; Deviere J. 1998. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28(6):1607-15. PubMed: 9828225 MGI: J:106536
Lu L; Ma J; Wang X; Wang J; Zhang F; Yu J; He G; Xu B; Brand DD; Horwitz DA; Shi W; Zheng SG. 2010. Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur J Immunol 40(1):142-52. PubMed: 19943263 MGI: J:155683
Luan B; Goodarzi MO; Phillips NG; Guo X; Chen YD; Yao J; Allison M; Rotter JI; Shaw R; Montminy M. 2014. Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4. Cell Metab 19(6):1058-65. PubMed: 24768298 MGI: J:215277
Ly LH; Smith R rd; Chapkin RS; McMurray DN. 2005. Dietary n-3 polyunsaturated fatty acids suppress splenic CD4(+) T cell function in interleukin (IL)-10(-/-) mice. Clin Exp Immunol 139(2):202-9. PubMed: 15654818 MGI: J:105106
Lytle C; Tod TJ; Vo KT; Lee JW; Atkinson RD; Straus DS. 2005. The Peroxisome Proliferator-Activated Receptor gamma Ligand Rosiglitazone Delays the Onset of Inflammatory Bowel Disease in Mice with Interleukin 10 Deficiency. Inflamm Bowel Dis 11(3):231-43. PubMed: 15735429 MGI: J:97868
MacKenzie KF; Van Den Bosch MW; Naqvi S; Elcombe SE; McGuire VA; Reith AD; Blackshear PJ; Dean JL; Arthur JS. 2013. MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop. Mol Cell Biol 33(7):1456-67. PubMed: 23382072 MGI: J:203325
Machado FS; Esper L; Dias A; Madan R; Gu Y; Hildeman D; Serhan CN; Karp CL; Aliberti J. 2008. Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6. J Exp Med 205(5):1077-86. PubMed: 18411340 MGI: J:136277
Mackenzie KF; Clark K; Naqvi S; McGuire VA; Noehren G; Kristariyanto Y; van den Bosch M; Mudaliar M; McCarthy PC; Pattison MJ; Pedrioli PG; Barton GJ; Toth R; Prescott A; Arthur JS. 2013. PGE2 Induces Macrophage IL-10 Production and a Regulatory-like Phenotype via a Protein Kinase A-SIK-CRTC3 Pathway. J Immunol 190(2):565-77. PubMed: 23241891 MGI: J:191723
Madala SK; Pesce JT; Ramalingam TR; Wilson MS; Minnicozzi S; Cheever AW; Thompson RW; Mentink-Kane MM; Wynn TA. 2010. Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. J Immunol 184(7):3955-63. PubMed: 20181883 MGI: J:160097
Madsen KL; Doyle JS; Jewell LD; Tavernini MM; Fedorak RN. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116(5):1107-14. PubMed: 10220502 MGI: J:106688
Madsen KL; Doyle JS; Tavernini MM; Jewell LD; Rennie RP; Fedorak RN. 2000. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118(6):1094-105. PubMed: 10833484 MGI: J:107748
Madsen KL; Malfair D; Gray D; Doyle JS; Jewell LD; Fedorak RN. 1999. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 5(4):262-70. PubMed: 10579119 MGI: J:59872
Madureira P; Baptista M; Vieira M; Magalhaes V; Camelo A; Oliveira L; Ribeiro A; Tavares D; Trieu-Cuot P; Vilanova M; Ferreira P. 2007. Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol 178(3):1379-87. PubMed: 17237385 MGI: J:143659
Maeda A; Beissert S; Schwarz T; Schwarz A. 2008. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J Immunol 180(5):3065-71. PubMed: 18292529 MGI: J:131531
Mahler M; Most C; Schmidtke S; Sundberg J; Li R; Hedrich H; Churchill G. 2002. Genetics of Colitis Susceptibility in IL-10-Deficient Mice: Backcross versus F2 Results Contrasted by Principal Component Analysis. Genomics 80(3):274. PubMed: 12213197 MGI: J:78917
Makela MJ; Kanehiro A; Borish L; Dakhama A; Loader J; Joetham A; Xing Z; Jordana M; Larsen GL; Gelfand EW. 2000. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci U S A 97(11):6007-12. PubMed: 10811896 MGI: J:62283
Mane J; Pedrosa E; Loren V; Ojanguren I; Fluvia L; Cabre E; Rogler G; Gassull MA. 2009. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. J Nutr 139(3):603-10. PubMed: 19126671 MGI: J:145707
Manicassamy S; Ravindran R; Deng J; Oluoch H; Denning TL; Kasturi SP; Rosenthal KM; Evavold BD; Pulendran B. 2009. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 15(4):401-9. PubMed: 19252500 MGI: J:149376
Mansfield LS; Bell JA; Wilson DL; Murphy AJ; Elsheikha HM; Rathinam VA; Fierro BR; Linz JE; Young VB. 2007. C57BL/6 and Congenic Interleukin-10-Deficient Mice Can Serve as Models of Campylobacter jejuni Colonization and Enteritis. Infect Immun 75(3):1099-115. PubMed: 17130251 MGI: J:118502
Martin ME; Caspersen K; Dumler JS. 2001. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol 158(5):1881-8. PubMed: 11337387 MGI: J:69104
Mascanfroni ID; Yeste A; Vieira SM; Burns EJ; Patel B; Sloma I; Wu Y; Mayo L; Ben-Hamo R; Efroni S; Kuchroo VK; Robson SC; Quintana FJ. 2013. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 14(10):1054-63. PubMed: 23995234 MGI: J:208218
Maseda D; Candando KM; Smith SH; Kalampokis I; Weaver CT; Plevy SE; Poe JC; Tedder TF. 2013. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice. J Immunol 191(5):2780-95. PubMed: 23918988 MGI: J:205795
Masso-Welch PA; Merhige PM; Veeranki OL; Kuo SM. 2012. Loss of IL-10 decreases mouse postpubertal mammary gland development in the absence of inflammation. Immunol Invest 41(5):521-37. PubMed: 22594921 MGI: J:201573
Matlack R; Yeh K; Rosini L; Gonzalez D; Taylor J; Silberman D; Pennello A; Riggs J. 2006. Peritoneal macrophages suppress T-cell activation by amino acid catabolism. Immunology 117(3):386-95. PubMed: 16476058 MGI: J:107076
Matsumura Y; Byrne SN; Nghiem DX; Miyahara Y; Ullrich SE. 2006. A role for inflammatory mediators in the induction of immunoregulatory B cells. J Immunol 177(7):4810-7. PubMed: 16982922 MGI: J:139306
Matsushita T; Horikawa M; Iwata Y; Tedder TF. 2010. Regulatory B cells (b10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 185(4):2240-52. PubMed: 20624940 MGI: J:162387
Matta R; Barnard JA; Wancket LM; Yan J; Xue J; Grieves J; Frazier WJ; Nelin L; Cato AC; Liu Y. 2012. Knockout of Mkp-1 exacerbates colitis in Il-10-deficient mice. Am J Physiol Gastrointest Liver Physiol 302(11):G1322-35. PubMed: 22461024 MGI: J:191160
Maurer M; Seidel-Guyenot W; Metz M; Knop J; Steinbrink K. 2003. Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J Clin Invest 112(3):432-9. PubMed: 12865418 MGI: J:118509
Mayer-Barber KD; Andrade BB; Oland SD; Amaral EP; Barber DL; Gonzales J; Derrick SC; Shi R; Kumar NP; Wei W; Yuan X; Zhang G; Cai Y; Babu S; Catalfamo M; Salazar AM; Via LE; Barry CE 3rd; Sher A. 2014. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511(7507):99-103. PubMed: 24990750 MGI: J:213640
Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT. 2007. Regulatory T cells expressing interleukin 10 develop from Foxp3(+) and Foxp3(-) precursor cells in the absence of interleukin 10. Nat Immunol 8(9):931-41. PubMed: 17694059 MGI: J:124255
McBride S; Hoebe K; Georgel P; Janssen E. 2006. Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN. J Immunol 177(9):6122-8. PubMed: 17056539 MGI: J:140522
McCafferty DM; Sihota E; Muscara M; Wallace JL; Sharkey KA; Kubes P. 2000. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 279(1):G90-9. PubMed: 10898750 MGI: J:107861
McDole JR; Wheeler LW; McDonald KG; Wang B; Konjufca V; Knoop KA; Newberry RD; Miller MJ. 2012. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 483(7389):345-9. PubMed: 22422267 MGI: J:182576
McGeachy MJ; Bak-Jensen KS; Chen Y; Tato CM; Blumenschein W; McClanahan T; Cua DJ. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8(12):1390-7. PubMed: 17994024 MGI: J:127772
McPhee JB; Mena P; Zhang Y; Bliska JB. 2012. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM. Infect Immun 80(7):2519-27. PubMed: 22547545 MGI: J:186677
Mencacci A; Montagnoli C; Bacci A; Cenci E; Pitzurra L; Spreca A; Kopf M; Sharpe AH; Romani L. 2002. CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol 169(6):3180-90. PubMed: 12218136 MGI: J:120204
Menezes GB; Lee WY; Zhou H; Waterhouse CC; Cara DC; Kubes P. 2009. Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. J Immunol 183(11):7557-68. PubMed: 19917697 MGI: J:157512
Mesples B; Plaisant F; Gressens P. 2003. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 141(1-2):25-32. PubMed: 12644245 MGI: J:82655
Metghalchi S; Ponnuswamy P; Simon T; Haddad Y; Laurans L; Clement M; Dalloz M; Romain M; Esposito B; Koropoulis V; Lamas B; Paul JL; Cottin Y; Kotti S; Bruneval P; Callebert J; den Ruijter H; Launay JM; Danchin N; Sokol H; Tedgui A; Taleb S; Mallat Z. 2015. Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production. Cell Metab 22(3):460-71. PubMed: 26235422 MGI: J:228095
Metzger DW; Salmon SL; Kirimanjeswara G. 2013. Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection. Infect Immun 81(6):2022-7. PubMed: 23529615 MGI: J:199533
Minami M; Shimizu K; Okamoto Y; Folco E; Ilasaca ML; Feinberg MW; Aikawa M; Libby P. 2008. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem 283(15):9692-703. PubMed: 18270204 MGI: J:135247
Mittal R; Gonzalez-Gomez I; Panigrahy A; Goth K; Bonnet R; Prasadarao NV. 2010. IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med 207(6):1307-19. PubMed: 20498022 MGI: J:163420
Mizoguchi A; Mizoguchi E; Takedatsu H; Blumberg RS; Bhan AK. 2002. Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation. Immunity 16(2):219-30. PubMed: 11869683 MGI: J:74718
Mizushima T; Arakawa S; Sanada Y; Yoshino I; Miyazaki D; Urushima H; Tsujimoto Y; Ito T; Shimizu S. 2013. Inhibition of epithelial cell death by Bcl-2 improved chronic colitis in IL-10 KO mice. Am J Pathol 183(6):1936-44. PubMed: 24266926 MGI: J:207935
Mohamadzadeh M; Pfeiler EA; Brown JB; Zadeh M; Gramarossa M; Managlia E; Bere P; Sarraj B; Khan MW; Pakanati KC; Ansari MJ; O'Flaherty S; Barrett T; Klaenhammer TR. 2011. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 108 Suppl 1:4623-30. PubMed: 21282652 MGI: J:170355
Montufar-Solis D; Schaefer J; Hicks MJ; Klein JR. 2008. Massive but selective cytokine dysregulation in the colon of IL-10 / mice revealed by multiplex analysis. Int Immunol 20(1):141-54. PubMed: 18046045 MGI: J:129200
Morise Z; Eppihimer M; Granger DN; Anderson DC; Grisham MB. 1999. Effects of lipopolysaccharide on endothelial cell adhesion molecule expression in interleukin-10 deficient mice. Inflammation 23(2):99-110. PubMed: 10213266 MGI: J:56218
Mucida D; Kutchukhidze N; Erazo A; Russo M; Lafaille JJ; Curotto de Lafaille MA. 2005. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115(7):1923-33. PubMed: 15937545 MGI: J:99807
Muhlbauer M; Chilton PM; Mitchell TC; Jobin C. 2008. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice. J Biol Chem 283(21):14182-9. PubMed: 18375954 MGI: J:137573
Murai M; Turovskaya O; Kim G; Madan R; Karp CL; Cheroutre H; Kronenberg M. 2009. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10(11):1178-84. PubMed: 19783988 MGI: J:157749
Murata Y; Kotani T; Supriatna Y; Kitamura Y; Imada S; Kawahara K; Nishio M; Daniwijaya EW; Sadakata H; Kusakari S; Mori M; Kanazawa Y; Saito Y; Okawa K; Takeda-Morishita M; Okazawa H; Ohnishi H; Azuma T; Suzuki A; Matozaki T. 2015. Protein tyrosine phosphatase SAP-1 protects against colitis through regulation of CEACAM20 in the intestinal epithelium. Proc Natl Acad Sci U S A 112(31):E4264-71. PubMed: 26195794 MGI: J:226057
Murphy ML; Wille U; Villegas EN; Hunter CA; Farrell JP. 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 31(10):2848-56. PubMed: 11592059 MGI: J:72355
Murphy SP; Fast LD; Hanna NN; Sharma S. 2005. Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 175(6):4084-90. PubMed: 16148158 MGI: J:116699
Murray PJ; Young RA. 1999. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 67(6):3087-95. PubMed: 10338525 MGI: J:55136
Murugaiyan G; Beynon V; Pires Da Cunha A; Joller N; Weiner HL. 2012. IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27. J Immunol 189(11):5277-83. PubMed: 23125412 MGI: J:190977
Myers D Jr; Farris D; Hawley A; Wrobleski S; Chapman A; Stoolman L; Knibbs R; Strieter R; Wakefield T. 2002. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 108(2):212-21. PubMed: 12505044 MGI: J:103110
Nagamatsu K; Kuwae A; Konaka T; Nagai S; Yoshida S; Eguchi M; Watanabe M; Mimuro H; Koyasu S; Abe A. 2009. Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med 206(13):3073-88. PubMed: 20008527 MGI: J:155669
Nagamine CM; Rogers AB; Fox JG; Schauer DB. 2008. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice. Int J Cancer 122(4):832-8. PubMed: 17957786 MGI: J:135558
Nairz M; Schroll A; Haschka D; Dichtl S; Sonnweber T; Theurl I; Theurl M; Lindner E; Demetz E; Asshoff M; Bellmann-Weiler R; Muller R; Gerner RR; Moschen AR; Baumgartner N; Moser PL; Talasz H; Tilg H; Fang FC; Weiss G. 2015. Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response. Eur J Immunol 45(11):3073-86. PubMed: 26332507 MGI: J:233649
Naruse H; Hisamatsu T; Yamauchi Y; Chang JE; Matsuoka K; Kitazume MT; Arai K; Ando S; Kanai T; Kamada N; Hibi T. 2011. Intracellular bacteria recognition contributes to maximal interleukin (IL)-12 production by IL-10-deficient macrophages. Clin Exp Immunol 164(1):137-44. PubMed: 21352199 MGI: J:170705
Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ. 2008. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice. Am J Physiol Gastrointest Liver Physiol 294(2):G477-88. PubMed: 18048478 MGI: J:132202
Narushima S; Spitz DR; Oberley LW; Toyokuni S; Miyata T; Gunnett CA; Buettner GR; Zhang J; Ismail H; Lynch RG; Berg DJ. 2003. Evidence for oxidative stress in NSAID-induced colitis in IL10-/- mice. Free Radic Biol Med 34(9):1153-66. PubMed: 12706496 MGI: J:119439
Navid F; Boniotto M; Walker C; Ahrens K; Proksch E; Sparwasser T; Muller W; Schwarz T; Schwarz A. 2012. Induction of regulatory T cells by a murine beta-defensin. J Immunol 188(2):735-43. PubMed: 22174455 MGI: J:180788
Nemeth K; Leelahavanichkul A; Yuen PS; Mayer B; Parmelee A; Doi K; Robey PG; Leelahavanichkul K; Koller BH; Brown JM; Hu X; Jelinek I; Star RA; Mezey E. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15(1):42-9. PubMed: 19098906 MGI: J:146566
Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M. 2007. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis. Gastroenterology 132(1):176-89. PubMed: 17241870 MGI: J:128223
Neves P; Lampropoulou V; Calderon-Gomez E; Roch T; Stervbo U; Shen P; Kuhl AA; Loddenkemper C; Haury M; Nedospasov SA; Kaufmann SH; Steinhoff U; Calado DP; Fillatreau S. 2010. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33(5):777-90. PubMed: 21093317 MGI: J:167006
Ng RL; Scott NM; Strickland DH; Gorman S; Grimbaldeston MA; Norval M; Waithman J; Hart PH. 2013. Altered immunity and dendritic cell activity in the periphery of mice after long-term engraftment with bone marrow from ultraviolet-irradiated mice. J Immunol 190(11):5471-84. PubMed: 23636055 MGI: J:204767
Niikura M; Kamiya S; Kita K; Kobayashi F. 2008. Coinfection with nonlethal murine malaria parasites suppresses pathogenesis caused by Plasmodium berghei NK65. J Immunol 180(10):6877-84. PubMed: 18453608 MGI: J:134868
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T. 2014. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Hum Mol Genet 23(15):3990-4000. PubMed: 24659498 MGI: J:211195
Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL. 2003. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 170(10):5152-8. PubMed: 12734362 MGI: J:123822
North RJ. 1998. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 113(1):55-8. PubMed: 9697983 MGI: J:114201
O'Mahony L; Feeney M; O'Halloran S; Murphy L; Kiely B; Fitzgibbon J; Lee G; O'Sullivan G; Shanahan F; Collins JK. 2001. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15(8):1219-25. PubMed: 11472326 MGI: J:70926
Oakley OR; Garvy BA; Humphreys S; Qureshi MH; Pomeroy C. 2008. Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus. Clin Exp Immunol 151(1):155-64. PubMed: 18005264 MGI: J:130172
Oh SJ; Kim JH; Chung DH. 2013. NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis. PLoS Pathog 9(5):e1003351. PubMed: 23675299 MGI: J:213406
Ohman MK; Shen Y; Obimba CI; Wright AP; Warnock M; Lawrence DA; Eitzman DT. 2008. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117(6):798-805. PubMed: 18212290 MGI: J:145083
Ohnmacht C; Park JH; Cording S; Wing JB; Atarashi K; Obata Y; Gaboriau-Routhiau V; Marques R; Dulauroy S; Fedoseeva M; Busslinger M; Cerf-Bensussan N; Boneca IG; Voehringer D; Hase K; Honda K; Sakaguchi S; Eberl G. 2015. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 349(6251):989-93. PubMed: 26160380 MGI: J:225908
Ohtani M; Nagai S; Kondo S; Mizuno S; Nakamura K; Tanabe M; Takeuchi T; Matsuda S; Koyasu S. 2008. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112(3):635-43. PubMed: 18492954 MGI: J:138434
Okada K; Fujita T; Minamoto K; Liao H; Naka Y; Pinsky DJ. 2000. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J Biol Chem 275(28):21468-76. PubMed: 10806208 MGI: J:63469
Okamura T; Sumitomo S; Morita K; Iwasaki Y; Inoue M; Nakachi S; Komai T; Shoda H; Miyazaki J; Fujio K; Yamamoto K. 2015. TGF-beta3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun 6:6329. PubMed: 25695838 MGI: J:221793
Oldenburg B; van Berge Henegouwen GP; Rennick D; Van Asbeck BS; Koningsberger JC. 2000. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 30(6):505-10. PubMed: 10849019 MGI: J:103312
Olszak T; Neves JF; Dowds CM; Baker K; Glickman J; Davidson NO; Lin CS; Jobin C; Brand S; Sotlar K; Wada K; Katayama K; Nakajima A; Mizuguchi H; Kawasaki K; Nagata K; Muller W; Snapper SB; Schreiber S; Kaser A; Zeissig S; Blumberg RS. 2014. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 509(7501):497-502. PubMed: 24717441 MGI: J:210436
Onyeagocha C; Hossain MS; Kumar A; Jones RM; Roback J; Gewirtz AT. 2009. Latent cytomegalovirus infection exacerbates experimental colitis. Am J Pathol 175(5):2034-42. PubMed: 19815702 MGI: J:154699
Oppmann B; Lesley R; Blom B; Timans JC; Xu Y; Hunte B; Vega F; Yu N; Wang J; Singh K; Zonin F; Vaisberg E; Churakova T; Liu M; Gorman D; Wagner J; Zurawski S; Liu Y; Abrams JS; Moore KW; Rennick D; de Waal-Malefyt R; Hannum C; Bazan JF; Kastelein RA. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13(5):715-25. PubMed: 11114383 MGI: J:65966
Ortega SB; Kashi VP; Tyler AF; Cunnusamy K; Mendoza JP; Karandikar NJ. 2013. The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis. J Immunol 191(1):117-26. PubMed: 23733879 MGI: J:205352
Otero DC; Poli V; David M; Rickert RC. 2006. Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3. J Immunol 177(10):6593-7. PubMed: 17082570 MGI: J:140502
Padigel UM; Alexander J; Farrell JP. 2003. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol 171(7):3705-10. PubMed: 14500669 MGI: J:85625
Padigel UM; Farrell JP. 2005. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J Immunol 174(10):6340-5. PubMed: 15879134 MGI: J:99049
Panes J; Aceituno M; Gil F; Miquel R; Pique JM; Salas A; McLean P. 2007. Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis. Am J Physiol Gastrointest Liver Physiol 293(4):G739-48. PubMed: 17656448 MGI: J:126663
Panjwani N; Mulvihill EE; Longuet C; Yusta B; Campbell JE; Brown TJ; Streutker C; Holland D; Cao X; Baggio LL; Drucker DJ. 2013. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. Endocrinology 154(1):127-39. PubMed: 23183176 MGI: J:194207
Panthel K; Faller G; Haas R. 2003. Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect Immun 71(2):794-800. PubMed: 12540559 MGI: J:81703
Papiernik M; de Moraes ML; Pontoux C; Vasseur F; Penit C. 1998. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10(4):371-8. PubMed: 9620592 MGI: J:110541
Parekh VV; Wu L; Olivares-Villagomez D; Wilson KT; Van Kaer L. 2013. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells. J Immunol 190(5):1948-60. PubMed: 23345328 MGI: J:193488
Park Y; Oh SJ; Chung DH. 2009. CD4(+)CD25(+) regulatory T cells attenuate Hypersensitivity Pneumonitis by suppressing IFN-gamma production by CD4(+) and CD8(+) T cells. J Leukoc Biol 86(6):1427-37. PubMed: 19741155 MGI: J:155623
Pasche B; Kalaydjiev S; Franz TJ; Kremmer E; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; Lengeling A; Busch DH. 2005. Sex-dependent susceptibility to Listeria monocytogenes infection is mediated by differential interleukin-10 production. Infect Immun 73(9):5952-60. PubMed: 16113316 MGI: J:100414
Pattison MJ; MacKenzie KF; Elcombe SE; Arthur JS. 2013. IFNbeta autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages. FEBS Lett 587(10):1496-503. PubMed: 23542035 MGI: J:197246
Pattison MJ; Mackenzie KF; Arthur JS. 2012. Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback. J Immunol 189(6):2784-92. PubMed: 22904308 MGI: J:189911
Peda JD; Salah SM; Wallace DP; Fields PE; Grantham CJ; Fields TA; Swenson-Fields KI. 2016. Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease. Dis Model Mech 9(9):1051-61. PubMed: 27491076 MGI: J:235358
Peng JK; Lin JS; Kung JT; Finkelman FD; Wu-Hsieh BA. 2005. The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection. Int Immunol 17(2):193-205. PubMed: 15642955 MGI: J:95565
Perez-Asensio FJ; Perpina U; Planas AM; Pozas E. 2013. Interleukin-10 regulates progenitor differentiation and modulates neurogenesis in adult brain. J Cell Sci 126(Pt 18):4208-19. PubMed: 23843621 MGI: J:210408
Perez-de-Puig I; Martin A; Gorina R; de la Rosa X; Martinez E; Planas AM. 2013. Induction of hemeoxygenase-1 expression after inhibition of hemeoxygenase activity promotes inflammation and worsens ischemic brain damage in mice. Neuroscience 243:22-32. PubMed: 23562577 MGI: J:201347
Perona-Wright G; Jenkins SJ; Crawford A; Gray D; Pearce EJ; MacDonald AS. 2006. Distinct sources and targets of IL-10 during dendritic cell-driven Th1 and Th2 responses in vivo. Eur J Immunol 36(9):2367-75. PubMed: 16917957 MGI: J:116745
Perry JA; Olver CS; Burnett RC; Avery AC. 2005. Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J Immunol 174(10):5921-5. PubMed: 15879082 MGI: J:98996
Pesce J; Kaviratne M; Ramalingam TR; Thompson RW; Urban JF Jr; Cheever AW; Young DA; Collins M; Grusby MJ; Wynn TA. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 116(7):2044-55. PubMed: 16778988 MGI: J:111712
Pils MC; Pisano F; Fasnacht N; Heinrich JM; Groebe L; Schippers A; Rozell B; Jack RS; Muller W. 2010. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur J Immunol 40(2):443-8. PubMed: 19941312 MGI: J:157787
Pimenta-Araujo R; Mascarell L; Huesca M; Cumano A; Bandeira A. 2002. Deoxyguanosine blocks allograft rejection of thymic epithelium but not lymphocyte infiltration and recognition. Eur J Immunol 32(1):77-86. PubMed: 11754006 MGI: J:73937
Pini M; Gove ME; Fayad R; Cabay RJ; Fantuzzi G. 2009. Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout mice. Am J Physiol Gastrointest Liver Physiol 296(2):G382-7. PubMed: 19074637 MGI: J:146374
Pitt JM; Stavropoulos E; Redford PS; Beebe AM; Bancroft GJ; Young DB; O'Garra A. 2012. Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J Immunol 189(8):4079-87. PubMed: 22972927 MGI: J:190516
Ploquin MJ; Eksmond U; Kassiotis G. 2011. B cells and TCR avidity determine distinct functions of CD4+ T cells in retroviral infection. J Immunol 187(6):3321-30. PubMed: 21841129 MGI: J:179252
Polyak S; Mach A; Porvasnik S; Dixon L; Conlon T; Erger KE; Acosta A; Wright AJ; Campbell-Thompson M; Zolotukhin I; Wasserfall C; Mah C. 2012. Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis. Am J Physiol Gastrointest Liver Physiol 302(3):G296-308. PubMed: 22114116 MGI: J:183314
Pompei L; Jang S; Zamlynny B; Ravikumar S; McBride A; Hickman SP; Salgame P. 2007. Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs. J Immunol 178(8):5192-9. PubMed: 17404302 MGI: J:145274
Pontoux C; Banz A; Papiernik M. 2002. Natural CD4 CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10. Int Immunol 14(2):233-9. PubMed: 11809742 MGI: J:113510
Poole DP; Lieu T; Pelayo JC; Eriksson EM; Veldhuis NA; Bunnett NW. 2015. Inflammation-induced abnormalities in the subcellular localization and trafficking of the neurokinin 1 receptor in the enteric nervous system. Am J Physiol Gastrointest Liver Physiol 309(4):G248-59. PubMed: 26138465 MGI: J:228656
Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z. 2004. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 24(8):1474-8. PubMed: 15178562 MGI: J:102225
Pratt JS; Sachen KL; Wood HD; Eaton KA; Young VB. 2006. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 74(8):4496-504. PubMed: 16861635 MGI: J:112296
Prendergast CT; Sanin DE; Cook PC; Mountford AP. 2015. CD4+ T cell hyporesponsiveness after repeated exposure to Schistosoma mansoni larvae is dependent upon interleukin-10. Infect Immun 83(4):1418-30. PubMed: 25624353 MGI: J:229275
Qureshi MH; Harmsen AG; Garvy BA. 2003. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J Immunol 170(2):1002-9. PubMed: 12517967 MGI: J:127133
Raisanen-Sokolowski A; Glysing-Jensen T; Russell ME. 1998. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol 153(5):1491-500. PubMed: 9811341 MGI: J:50766
Raisanen-Sokolowski A; Mottram PL; Glysing-Jensen T; Satoskar A; Russell ME. 1997. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. J Clin Invest 100(10):2449-56. PubMed: 9366559 MGI: J:44346
Rakoff-Nahoum S; Hao L; Medzhitov R. 2006. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25(2):319-29. PubMed: 16879997 MGI: J:113467
Ramaswamy K; Kumar P; He YX. 2000. A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J Immunol 165(8):4567-74. PubMed: 11035098 MGI: J:118566
Ranatunga D; Hedrich CM; Wang F; McVicar DW; Nowak N; Joshi T; Feigenbaum L; Grant LR; Stager S; Bream JH. 2009. A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome. Proc Natl Acad Sci U S A 106(40):17123-8. PubMed: 19805095 MGI: J:153695
Ray A; Basu S; Williams CB; Salzman NH; Dittel BN. 2012. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 188(7):3188-98. PubMed: 22368274 MGI: J:183107
Redpath S; Angulo A; Gascoigne NR; Ghazal P. 1999. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 162(11):6701-7. PubMed: 10352288 MGI: J:112114
Ren X; Akiyoshi K; Dziennis S; Vandenbark AA; Herson PS; Hurn PD; Offner H. 2011. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 31(23):8556-63. PubMed: 21653859 MGI: J:191555
Rhodes KA; Andrew EM; Newton DJ; Tramonti D; Carding SR. 2008. A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. Eur J Immunol 38(8):2274-83. PubMed: 18624301 MGI: J:138563
Richter K; Oxenius A. 2013. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcgammaR or complement. Eur J Immunol 43(9):2349-60. PubMed: 23749374 MGI: J:201331
Rifa'i M; Shi Z; Zhang SY; Lee YH; Shiku H; Isobe K; Suzuki H. 2008. CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. Int Immunol 20(7):937-47. PubMed: 18495626 MGI: J:137065
Ring S; Enk AH; Mahnke K. 2011. Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production. J Invest Dermatol 131(7):1494-502. PubMed: 21430704 MGI: J:182075
Ring S; Schafer SC; Mahnke K; Lehr HA; Enk AH. 2006. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 36(11):2981-92. PubMed: 17048272 MGI: J:117011
Rivollier A; He J; Kole A; Valatas V; Kelsall BL. 2012. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 209(1):139-55. PubMed: 22231304 MGI: J:181701
Rizzo LV; Morawetz RA; Miller-Rivero NE; Choi R; Wiggert B; Chan CC; Morse HC 3rd; Nussenblatt RB; Caspi RR. 1999. IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol 162(5):2613-22. PubMed: 10072503 MGI: J:110850
Roach DR; Martin E; Bean AG; Rennick DM; Briscoe H; Britton WJ. 2001. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol 54(1-2):163-70. PubMed: 11439163 MGI: J:80909
Roberts CT; White CA; Wiemer NG; Ramsay A; Robertson SA. 2003. Altered placental development in interleukin-10 null mutant mice. Placenta 24 Suppl A:S94-9. PubMed: 12842419 MGI: J:113180
Robertson SA; Care AS; Skinner RJ. 2007. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod 76(5):738-48. PubMed: 17215490 MGI: J:121947
Robertson SA; Skinner RJ; Care AS. 2006. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 177(7):4888-96. PubMed: 16982931 MGI: J:139303
Rodriguez W; Mold C; Kataranovski M; Hutt JA; Marnell LL; Verbeek JS; Du Clos TW. 2007. C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors. J Immunol 178(1):530-8. PubMed: 17182593 MGI: J:141920
Rodriguez-Feo JA; Puerto M; Fernandez-Mena C; Verdejo C; Lara JM; Diaz-Sanchez M; Alvarez E; Vaquero J; Marin-Jimenez I; Banares R; Menchen L. 2015. A new role for reticulon-4B/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 308(12):G981-93. PubMed: 25907690 MGI: J:224691
Roelofs-Haarhuis K; Wu X; Gleichmann E. 2004. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 173(2):1043-50. PubMed: 15240692 MGI: J:91933
Roffe E; Rothfuchs AG; Santiago HC; Marino AP; Ribeiro-Gomes FL; Eckhaus M; Antonelli LR; Murphy PM. 2012. IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J Immunol 188(2):649-60. PubMed: 22156594 MGI: J:180798
Ronet C; Hauyon-La Torre Y; Revaz-Breton M; Mastelic B; Tacchini-Cottier F; Louis J; Launois P. 2010. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol 184(2):886-94. PubMed: 19966209 MGI: J:159430
Roque S; Nobrega C; Appelberg R; Correia-Neves M. 2007. IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J Immunol 178(12):8028-35. PubMed: 17548640 MGI: J:148580
Rosborough BR; Raich-Regue D; Matta BM; Lee K; Gan B; DePinho RA; Hackstein H; Boothby M; Turnquist HR; Thomson AW. 2013. Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction. Blood 121(18):3619-30. PubMed: 23444404 MGI: J:197572
Rothfuchs AG; Gigliotti D; Palmblad K; Andersson U; Wigzell H; Rottenberg ME. 2001. IFN-alphabeta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol 167(11):6453-61. PubMed: 11714812 MGI: J:72825
Roy N; Barnett M; Knoch B; Dommels Y; McNabb W. 2007. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: Transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat Res 622(1-2):103-16. PubMed: 17574631 MGI: J:124308
Rubtsov YP; Rasmussen JP; Chi EY; Fontenot J; Castelli L; Ye X; Treuting P; Siewe L; Roers A; Henderson WR Jr; Muller W; Rudensky AY. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546-58. PubMed: 18387831 MGI: J:134513
Ruiz PA; Shkoda A; Kim SC; Sartor RB; Haller D. 2005. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 174(5):2990-9. PubMed: 15728512 MGI: J:97722
Ryan SO; Johnson JL; Cobb BA. 2013. Neutrophils confer T cell resistance to myeloid-derived suppressor cell-mediated suppression to promote chronic inflammation. J Immunol 190(10):5037-47. PubMed: 23576679 MGI: J:202566
Rynda A; Maddaloni M; Mierzejewska D; Ochoa-Reparaz J; Maslanka T; Crist K; Riccardi C; Barszczewska B; Fujihashi K; McGhee JR; Pascual DW. 2008. Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol 180(8):5187-200. PubMed: 18390700 MGI: J:134246
Saadane A; Soltys J; Berger M. 2005. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice. J Allergy Clin Immunol 115(2):405-11. PubMed: 15696103 MGI: J:105450
Sadler CH; Rutitzky LI; Stadecker MJ; Wilson RA. 2003. IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni. Eur J Immunol 33(4):880-8. PubMed: 12672053 MGI: J:115702
Sahay B; Singh A; Gnanamani A; Patsey RL; Blalock JE; Sellati TJ. 2011. CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis. Am J Pathol 178(2):724-34. PubMed: 21281805 MGI: J:169078
Sanni LA; Jarra W; Li C; Langhorne J. 2004. Cerebral edema and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi. Infect Immun 72(5):3054-8. PubMed: 15102820 MGI: J:89479
Sarangi PP; Sehrawat S; Suvas S; Rouse BT. 2008. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J Immunol 180(9):6297-306. PubMed: 18424753 MGI: J:134522
Sarasin-Filipowicz M; Wang X; Yan M; Duong FH; Poli V; Hilton DJ; Zhang DE; Heim MH. 2009. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol Cell Biol 29(17):4841-51. PubMed: 19564419 MGI: J:152613
Sasaki H; Hou L; Belani A; Wang CY; Uchiyama T; Muller R; Stashenko P. 2000. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 165(7):3626-30. PubMed: 11034365 MGI: J:118728
Sasaki H; Okamatsu Y; Kawai T; Kent R; Taubman M; Stashenko P. 2004. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res 39(6):432-41. PubMed: 15491348 MGI: J:103519
Sawant DV; Sehra S; Nguyen ET; Jadhav R; Englert K; Shinnakasu R; Hangoc G; Broxmeyer HE; Nakayama T; Perumal NB; Kaplan MH; Dent AL. 2012. Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function. J Immunol 189(10):4759-69. PubMed: 23053511 MGI: J:190587
Sayi A; Kohler E; Toller IM; Flavell RA; Muller W; Roers A; Muller A. 2011. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol 186(2):878-90. PubMed: 21149607 MGI: J:168773
Scapini P; Lamagna C; Hu Y; Lee K; Tang Q; Defranco AL; Lowell CA. 2011. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc Natl Acad Sci U S A 108(41):E823-32. PubMed: 21911371 MGI: J:177380
Schaefer JS; Montufar-Solis D; Vigneswaran N; Klein JR. 2011. Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol 187(11):5834-41. PubMed: 22043014 MGI: J:179720
Scheckelhoff M; Deepe GS Jr. 2005. A deficiency in gamma interferon or interleukin-10 modulates T-Cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun 73(4):2129-34. PubMed: 15784555 MGI: J:97204
Scheinin T; Butler DM; Salway F; Scallon B; Feldmann M. 2003. Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis. Clin Exp Immunol 133(1):38-43. PubMed: 12823276 MGI: J:84100
Schmitt EG; Haribhai D; Jeschke JC; Co DO; Ziegelbauer J; Yan K; Iwakura Y; Mishra MK; Simpson P; Salzman NH; Williams CB. 2013. Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression. J Immunol 191(11):5460-76. PubMed: 24163409 MGI: J:207015
Schmitt EG; Haribhai D; Williams JB; Aggarwal P; Jia S; Charbonnier LM; Yan K; Lorier R; Turner A; Ziegelbauer J; Georgiev P; Simpson P; Salzman NH; Hessner MJ; Broeckel U; Chatila TA; Williams CB. 2012. IL-10 Produced by Induced Regulatory T Cells (iTregs) Controls Colitis and Pathogenic Ex-iTregs during Immunotherapy. J Immunol 189(12):5638-48. PubMed: 23125413 MGI: J:190976
Schulke S; Wolfheimer S; Gadermaier G; Wangorsch A; Siebeneicher S; Briza P; Spreitzer I; Schiller D; Loeschner B; Uematsu S; Ryffel B; Akira S; Waibler Z; Vieths S; Toda M; Scheurer S. 2014. Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC. PLoS One 9(2):e87822. PubMed: 24516564 MGI: J:212957
Schwandt T; Schumak B; Gielen GH; Jungerkes F; Schmidbauer P; Klocke K; Staratschek-Jox A; van Rooijen N; Kraal G; Ludwig-Portugall I; Franken L; Wehner S; Kalff JC; Weber O; Kirschning C; Coch C; Kalinke U; Wenzel J; Kurts C; Zawatzky R; Holzmann B; Layland L; Schultze JL; Burgdorf S; den Haan JM; Knolle PA; Limmer A. 2012. Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. EMBO J 31(1):201-13. PubMed: 22036947 MGI: J:180238
Scumpia PO; Delano MJ; Kelly KM; O'Malley KA; Efron PA; McAuliffe PF; Brusko T; Ungaro R; Barker T; Wynn JL; Atkinson MA; Reeves WH; Salzler MJ; Moldawer LL. 2006. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 177(11):7943-9. PubMed: 17114466 MGI: J:140690
Seewaldt S; Alferink J; Forster I. 2002. Interleukin-10 is crucial for maintenance but not for developmental induction of peripheral T cell tolerance. Eur J Immunol 32(12):3607-16. PubMed: 12516547 MGI: J:80858
Sefik E; Geva-Zatorsky N; Oh S; Konnikova L; Zemmour D; McGuire AM; Burzyn D; Ortiz-Lopez A; Lobera M; Yang J; Ghosh S; Earl A; Snapper SB; Jupp R; Kasper D; Mathis D; Benoist C. 2015. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349(6251):993-7. PubMed: 26272906 MGI: J:226179
Segal BM; Dwyer BK; Shevach EM. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 187(4):537-46. PubMed: 9463404 MGI: J:118559
Selvaraj RK; Geiger TL. 2008. Mitigation of Experimental Allergic Encephalomyelitis by TGF-{beta} Induced Foxp3+ Regulatory T Lymphocytes through the Induction of Anergy and Infectious Tolerance. J Immunol 180(5):2830-2838. PubMed: 18292504 MGI: J:131562
Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A. 2001. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol 166(2):1352-9. PubMed: 11145720 MGI: J:109883
Settles EW; Moser LA; Harris TH; Knoll LJ. 2014. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria. Infect Immun 82(3):1343-53. PubMed: 24396042 MGI: J:209405
Sewnath ME; Olszyna DP; Birjmohun R; ten Kate FJ; Gouma DJ; van Der Poll T. 2001. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 166(10):6323-31. PubMed: 11342656 MGI: J:69347
Shaler CR; Kugathasan K; McCormick S; Damjanovic D; Horvath C; Small CL; Jeyanathan M; Chen X; Yang PC; Xing Z. 2011. Pulmonary mycobacterial granuloma increased IL-10 production contributes to establishing a symbiotic host-microbe microenvironment. Am J Pathol 178(4):1622-34. PubMed: 21406169 MGI: J:169923
Shattuck-Brandt RL; Varilek GW; Radhika A; Yang F; Washington MK; DuBois RN. 2000. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice Gastroenterology 118(2):337-45. PubMed: 10648462 MGI: J:60015
Shaw MH; Freeman GJ; Scott MF; Fox BA; Bzik DJ; Belkaid Y; Yap GS. 2006. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J Immunol 176(12):7263-71. PubMed: 16751369 MGI: J:132232
Sheikh SZ; Hegazi RA; Kobayashi T; Onyiah JC; Russo SM; Matsuoka K; Sepulveda AR; Li F; Otterbein LE; Plevy SE. 2011. An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol 186(9):5506-13. PubMed: 21444764 MGI: J:173113
Sheil B; MacSharry J; O'Callaghan L; O'Riordan A; Waters A; Morgan J; Collins JK; O'Mahony L; Shanahan F. 2006. Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin Exp Immunol 144(2):273-80. PubMed: 16634801 MGI: J:108129
Shen P; Roch T; Lampropoulou V; O'Connor RA; Stervbo U; Hilgenberg E; Ries S; Dang VD; Jaimes Y; Daridon C; Li R; Jouneau L; Boudinot P; Wilantri S; Sakwa I; Miyazaki Y; Leech MD; McPherson RC; Wirtz S; Neurath M; Hoehlig K; Meinl E; Grutzkau A; Grun JR; Horn K; Kuhl AA; Dorner T; Bar-Or A; Kaufmann SH; Anderton SM; Fillatreau S. 2014. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507(7492):366-70. PubMed: 24572363 MGI: J:208891
Shen Z; Feng Y; Muthupalani S; Sheh A; Cheaney LE; Kaufman CA; Gong G; Paster BJ; Fox JG. 2016. Novel Helicobacter species H.japonicum isolated from laboratory mice from Japan induces typhlocolitis and lower bowel carcinoma in C57BL/129 IL10-/- mice. Carcinogenesis 37(12):1190-1198. PubMed: 27655833 MGI: J:238128
Shen Z; Feng Y; Rogers AB; Rickman B; Whary MT; Xu S; Clapp KM; Boutin SR; Fox JG. 2009. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect Immun 77(6):2508-16. PubMed: 19307212 MGI: J:149367
Shi LZ; Kalupahana NS; Turnis ME; Neale G; Hock H; Vignali DA; Chi H. 2013. Inhibitory role of the transcription repressor Gfi1 in the generation of thymus-derived regulatory T cells. Proc Natl Acad Sci U S A 110(34):E3198-205. PubMed: 23918371 MGI: J:200673
Shi M; Ye Z; Umeshappa KS; Moyana T; Xiang J. 2007. Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phase. Biochem Biophys Res Commun 360(3):702-7. PubMed: 17618911 MGI: J:123025
Shibata Y; Foster LA; Kurimoto M; Okamura H; Nakamura RM; Kawajiri K; Justice JP; Van Scott MR; Myrvik QN; Metzger WJ. 1998. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J Immunol 161(8):4283-8. PubMed: 9780204 MGI: J:112144
Shibata Y; Gabbard J; Yamashita M; Tsuji S; Smith M; Nishiyama A; Henriksen RA; Myrvik QN. 2006. Heat-killed BCG induces biphasic cyclooxygenase 2+ splenic macrophage formation--role of IL-10 and bone marrow precursors. J Leukoc Biol 80(3):590-8. PubMed: 16822852 MGI: J:112580
Shibata Y; Nishiyama A; Ohata H; Gabbard J; Myrvik QN; Henriksen RA. 2005. Differential effects of IL-10 on prostaglandin H synthase-2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages. J Leukoc Biol 77(4):544-51. PubMed: 15657087 MGI: J:97441
Shiraki M; Aihara H; Kinouchi Y; Takahashi S; Oki M; Noguchi M; Takahashi K; Miyazaki J; Shimosegawa T. 2004. IL-12 p40 prevents the development of chronic enterocolitis in IL-10-deficient mice. Lab Invest 84(11):1491-500. PubMed: 15448706 MGI: J:94422
Shmelkov SV; Butler JM; Hooper AT; Hormigo A; Kushner J; Milde T; St Clair R; Baljevic M; White I; Jin DK; Chadburn A; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; D'Angelica M; Kemeny N; Lyden D; Rafii S. 2008. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118(6):2111-20. PubMed: 18497886 MGI: J:137714
Shreiner AB; Murdock BJ; Sadighi Akha AA; Falkowski NR; Christensen PJ; White ES; Hogaboam CM; Huffnagle GB. 2012. Repeated Exposure to Aspergillus fumigatus Conidia Results in CD4+ T Cell-Dependent and -Independent Pulmonary Arterial Remodeling in a Mixed Th1/Th2/Th17 Microenvironment That Requires Interleukin-4 (IL-4) and IL-10. Infect Immun 80(1):388-97. PubMed: 22064716 MGI: J:179004
Siegmund B; Sennello JA; Lehr HA; Batra A; Fedke I; Zeitz M; Fantuzzi G. 2004. Development of intestinal inflammation in double IL-10- and leptin-deficient mice. J Leukoc Biol 76(4):782-6. PubMed: 15240754 MGI: J:93117
Siewe L; Bollati-Fogolin M; Wickenhauser C; Krieg T; Muller W; Roers A. 2006. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur J Immunol 36(12):3248-55. PubMed: 17111348 MGI: J:117122
Sikka G; Miller KL; Steppan J; Pandey D; Jung SM; Fraser CD 3rd; Ellis C; Ross D; Vandegaer K; Bedja D; Gabrielson K; Walston JD; Berkowitz DE; Barouch LA. 2013. Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Exp Gerontol 48(2):128-35. PubMed: 23159957 MGI: J:210217
Silvestre JS; Mallat Z; Tamarat R; Duriez M; Tedgui A; Levy BI. 2001. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res 89(3):259-64. PubMed: 11485976 MGI: J:115612
Sindhava V; Woodman ME; Stevenson B; Bondada S. 2010. Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection. PLoS One 5(7):e11445. PubMed: 20625435 MGI: J:163123
Sing A; Roggenkamp A; Geiger AM; Heesemann J. 2002. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 168(3):1315-21. PubMed: 11801671 MGI: J:127288
Singh UP; Singh S; Singh R; Karls RK; Quinn FD; Potter ME; Lillard JW Jr. 2007. Influence of Mycobacterium avium subsp. paratuberculosis on colitis development and specific immune responses during disease. Infect Immun 75(8):3722-8. PubMed: 17502388 MGI: J:123357
Singh UP; Singh S; Taub DD; Lillard JW Jr. 2003. Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10(-/-) mice. J Immunol 171(3):1401-6. PubMed: 12874231 MGI: J:84654
Sinha P; Clements VK; Bunt SK; Albelda SM; Ostrand-Rosenberg S. 2007. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179(2):977-83. PubMed: 17617589 MGI: J:149400
Skelsey ME; Mayhew E; Niederkorn JY. 2003. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 110(1):18-29. PubMed: 12941137 MGI: J:113598
Slight SR; Monin L; Gopal R; Avery L; Davis M; Cleveland H; Oury TD; Rangel-Moreno J; Khader SA. 2013. IL-10 Restrains IL-17 to Limit Lung Pathology Characteristics following Pulmonary Infection with Francisella tularensis Live Vaccine Strain. Am J Pathol 183(5):1397-404. PubMed: 24007881 MGI: J:202032
Sohn BH; Moon HB; Kim TY; Kang HS; Bae YS; Lee KK; Kim SJ. 2001. Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem J 360(Pt 1):31-8. PubMed: 11695989 MGI: J:128126
Soltys J; Bonfield T; Chmiel J; Berger M. 2002. Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages. J Immunol 168(4):1903-10. PubMed: 11823525 MGI: J:74476
Sonderegger FL; Ma Y; Maylor-Hagan H; Brewster J; Huang X; Spangrude GJ; Zachary JF; Weis JH; Weis JJ. 2012. Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-gamma-mediated Lyme arthritis. J Immunol 188(3):1381-93. PubMed: 22180617 MGI: J:180776
Sonoda KH; Faunce DE; Taniguchi M; Exley M; Balk S; Stein-Streilein J. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 166(1):42-50. PubMed: 11123275 MGI: J:125981
Spach KM; Nashold FE; Dittel BN; Hayes CE. 2006. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177(9):6030-7. PubMed: 17056528 MGI: J:140527
Specht S; Volkmann L; Wynn T; Hoerauf A. 2004. Interleukin-10 (IL-10) counterregulates IL-4-dependent effector mechanisms in Murine Filariasis. Infect Immun 72(11):6287-93. PubMed: 15501755 MGI: J:93273
Speiran K; Bailey DP; Fernando J; Macey M; Barnstein B; Kolawole M; Curley D; Watowich SS; Murray PJ; Oskeritzian C; Ryan JJ. 2009. Endogenous suppression of mast cell development and survival by IL-4 and IL-10. J Leukoc Biol 85(5):826-36. PubMed: 19228815 MGI: J:149777
Spence S; Fitzsimons A; Boyd CR; Kessler J; Fitzgerald D; Elliott J; Gabhann JN; Smith S; Sica A; Hams E; Saunders SP; Jefferies CA; Fallon PG; McAuley DF; Kissenpfennig A; Johnston JA. 2013. Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 38(1):66-78. PubMed: 23177319 MGI: J:192314
Spencer DM; Veldman GM; Banerjee S; Willis J; Levine AD. 2002. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122(1):94-105. PubMed: 11781285 MGI: J:73628
Spight D; Zhao B; Haas M; Wert S; Denenberg A; Shanley TP. 2005. Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo. Am J Physiol Lung Cell Mol Physiol 288(2):L251-65. PubMed: 15466252 MGI: J:101234
Spolski R; Kim HP; Zhu W; Levy DE; Leonard WJ. 2009. IL-21 mediates suppressive effects via its induction of IL-10. J Immunol 182(5):2859-67. PubMed: 19234181 MGI: J:146251
Srivastava AS; Feng Z; Mishra R; Malhotra R; Kim HS; Carrier E. 2007. Embryonic stem cells ameliorate piroxicam-induced colitis in IL10-/- KO mice. Biochem Biophys Res Commun 361(4):953-9. PubMed: 17692287 MGI: J:124266
Stein P; Weber M; Prufer S; Schmid B; Schmitt E; Probst HC; Waisman A; Langguth P; Schild H; Radsak MP. 2011. Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization. PLoS One 6(11):e27911. PubMed: 22114725 MGI: J:180954
Stone SC; Rossetti RA; Bolpetti A; Boccardo E; Souza PS; Lepique AP. 2014. HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells. J Leukoc Biol 96(4):619-31. PubMed: 24970861 MGI: J:220048
Sturlan S; Oberhuber G; Beinhauer BG; Tichy B; Kappel S; Wang J; Rogy MA. 2001. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis 22(4):665-71. PubMed: 11285204 MGI: J:68476
Sugimoto K; Ogawa A; Shimomura Y; Nagahama K; Mizoguchi A; Bhan AK. 2007. Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology 133(1):124-36. PubMed: 17631137 MGI: J:128298
Sullivan VV; Hawley AE; Farris DM; Knipp BS; Varga AJ; Wrobleski SK; Thanapron P; Eagleton MJ; Myers DD; Fowlkes JB; Wakefield TW. 2003. Decrease in fibrin content of venous thrombi in selectin-deficient mice. J Surg Res 109(1):1-7. PubMed: 12591228 MGI: J:119317
Sumitomo S; Fujio K; Okamura T; Morita K; Ishigaki K; Suzukawa K; Kanaya K; Kondo K; Yamasoba T; Furukawa A; Kitahara N; Shoda H; Shibuya M; Okamoto A; Yamamoto K. 2013. Transcription factor early growth response 3 is associated with the TGF-beta1 expression and the regulatory activity of CD4-positive T cells in vivo. J Immunol 191(5):2351-9. PubMed: 23904169 MGI: J:205814
Sun K; Metzger DW. 2008. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14(5):558-64. PubMed: 18438414 MGI: J:136669
Suzuki Y; Sher A; Yap G; Park D; Neyer LE; Liesenfeld O; Fort M; Kang H; Gufwoli E. 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 164(10):5375-82. PubMed: 10799901 MGI: J:62121
Svensson L; Arvola M; Sallstrom M; Holmdahl R; Mattsson R. 2001. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol 51(1):3-7. PubMed: 11438376 MGI: J:70597
Szalay G; Sauter M; Hald J; Weinzierl A; Kandolf R; Klingel K. 2006. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 169(6):2085-93. PubMed: 17148671 MGI: J:116221
Tadagavadi RK; Reeves WB. 2010. Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells. J Immunol 185(8):4904-11. PubMed: 20844196 MGI: J:219402
Takabayshi K; Corr M; Hayashi T; Redecke V; Beck L; Guiney D; Sheppard D; Raz E. 2006. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 24(4):475-87. PubMed: 16618605 MGI: J:113350
Takai A; Marusawa H; Minaki Y; Watanabe T; Nakase H; Kinoshita K; Tsujimoto G; Chiba T. 2012. Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation. Oncogene 31(13):1733-42. PubMed: 21841819 MGI: J:186149
Takiishi T; Tadokoro CE; Rizzo LV; de Moraes LV. 2012. Early IL-10 production is essential for syngeneic graft acceptance. J Leukoc Biol 92(2):259-64. PubMed: 22416256 MGI: J:186218
Tanikawa T; Wilke CM; Kryczek I; Chen GY; Kao J; Nunez G; Zou W. 2012. Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res 72(2):420-9. PubMed: 22123924 MGI: J:181148
Tao H; Lu L; Xia Y; Dai F; Wang Y; Bao Y; Lundy SK; Ito F; Pan Q; Zhang X; Zheng F; Shu G; Fang B; Jiang J; Xia J; Huang S; Li Q; Chang AE. 2015. Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10. Eur J Immunol 45(4):999-1009. PubMed: 25545618 MGI: J:228984
Tarrant TK; Silver PB; Wahlsten JL; Rizzo LV; Chan CC; Wiggert B; Caspi RR. 1999. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 189(2):219-30. PubMed: 9892605 MGI: J:119614
Tavares D; Ferreira P; Arala-Chaves M. 2000. Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis 182(1):266-73. PubMed: 10882606 MGI: J:135875
Tawara I; Sun Y; Liu C; Toubai T; Nieves E; Evers R; Alrubaie M; Mathewson N; Tamaki H; Reddy P. 2012. Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease. J Leukoc Biol 91(4):667-75. PubMed: 22262800 MGI: J:184092
TeKippe M; Harrison DE; Chen J. 2003. Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp Hematol 31(6):521-7. PubMed: 12829028 MGI: J:115677
Tewari N; Kalkunte S; Murray DW; Sharma S. 2009. The water channel aquaporin 1 is a novel molecular target of polychlorinated biphenyls for in utero anomalies. J Biol Chem 284(22):15224-32. PubMed: 19332547 MGI: J:150508
Thackray AM; McKenzie AN; Klein MA; Lauder A; Bujdoso R. 2004. Accelerated prion disease in the absence of interleukin-10. J Virol 78(24):13697-707. PubMed: 15564479 MGI: J:94220
Thaxton JE; Nevers T; Lippe EO; Blois SM; Saito S; Sharma S. 2013. NKG2D Blockade Inhibits Poly(I:C)-Triggered Fetal Loss in Wild Type but Not in IL-10-/- Mice. J Immunol 190(7):3639-47. PubMed: 23455498 MGI: J:194828
Thaxton JE; Romero R; Sharma S. 2009. TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 183(2):1144-54. PubMed: 19561095 MGI: J:151664
Toller IM; Altmeyer M; Kohler E; Hottiger MO; Muller A. 2010. Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia. Cancer Res 70(14):5912-22. PubMed: 20634404 MGI: J:162229
Tolstanova G; Deng X; French SW; Lungo W; Paunovic B; Khomenko T; Ahluwalia A; Kaplan T; Dacosta-Iyer M; Tarnawski A; Szabo S; Sandor Z. 2012. Early endothelial damage and increased colonic vascular permeability in the development of experimental ulcerative colitis in rats and mice. Lab Invest 92(1):9-21. PubMed: 21894149 MGI: J:180036
Tomczak MF; Erdman SE; Davidson A; Wang YY; Nambiar PR; Rogers AB; Rickman B; Luchetti D; Fox JG; Horwitz BH. 2006. Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B. J Immunol 177(10):7332-9. PubMed: 17082652 MGI: J:140612
Tomczak MF; Gadjeva M; Wang YY; Brown K; Maroulakou I; Tsichlis PN; Erdman SE; Fox JG; Horwitz BH. 2006. Defective activation of ERK in macrophages lacking the p50/p105 subunit of NF-kappaB is responsible for elevated expression of IL-12 p40 observed after challenge with Helicobacter hepaticus. J Immunol 176(2):1244-51. PubMed: 16394015 MGI: J:126439
Tongren JE; Corran PH; Jarra W; Langhorne J; Riley EM. 2005. Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins. Infect Immun 73(12):8119-29. PubMed: 16299306 MGI: J:104297
Tosello Boari J; Amezcua Vesely MC; Bermejo DA; Ramello MC; Montes CL; Cejas H; Gruppi A; Acosta Rodriguez EV. 2012. IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS Pathog 8(4):e1002658. PubMed: 22577359 MGI: J:195387
Toth LA; Opp MR. 2001. Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice. Am J Physiol Regul Integr Comp Physiol 280(6):R1806-14. PubMed: 11353686 MGI: J:114404
Toto P; Feliciani C; Amerio P; Suzuki H; Wang B; Shivji GM; Woodley D; Sauder DN. 2000. Immune modulation in pemphigus vulgaris: role of CD28 and IL-10. J Immunol 164(1):522-9. PubMed: 10605050 MGI: J:125983
Tourneur L; Damotte D; Marion S; Mistou S; Chiocchia G. 2002. IL-10 is necessary for FasL-induced protection from experimental autoimmune thyroiditis but not for FasL-induced immune deviation. Eur J Immunol 32(5):1292-9. PubMed: 11981816 MGI: J:76540
Tournoy KG; Kips JC; Pauwels RA. 2001. Counterbalancing of TH2-driven allergic airway inflammation by IL-12 does not require IL-10. J Allergy Clin Immunol 107(3):483-91. PubMed: 11240949 MGI: J:106293
Trandem K; Zhao J; Fleming E; Perlman S. 2011. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J Immunol 186(6):3642-52. PubMed: 21317392 MGI: J:169759
Tso VK; Sydora BC; Foshaug RR; Churchill TA; Doyle J; Slupsky CM; Fedorak RN. 2013. Metabolomic profiles are gender, disease and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease. PLoS One 8(7):e67654. PubMed: 23874435 MGI: J:204413
Tu H; Juelich T; Smith EM; Tyring SK; Rady PL; Hughes TK Jr. 2003. Evidence for endogenous interleukin-10 during nociception. J Neuroimmunol 139(1-2):145-9. PubMed: 12799032 MGI: J:119039
Turner JK; Xu JL; Tapping RI. 2009. Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice. Infect Immun 77(1):367-73. PubMed: 18955473 MGI: J:144076
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M. 2006. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4. Int Immunol 18(9):1397-404. PubMed: 16914507 MGI: J:113387
Ueda Y; Kayama H; Jeon SG; Kusu T; Isaka Y; Rakugi H; Yamamoto M; Takeda K. 2010. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int Immunol 22(12):953-62. PubMed: 21051439 MGI: J:167353
Ueno A; Cho S; Cheng L; Wang J; Hou S; Nakano H; Santamaria P; Yang Y. 2007. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes 56(6):1686-93. PubMed: 17360980 MGI: J:126514
Uhlig HH; Coombes J; Mottet C; Izcue A; Thompson C; Fanger A; Tannapfel A; Fontenot JD; Ramsdell F; Powrie F. 2006. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 177(9):5852-60. PubMed: 17056509 MGI: J:140535
Van Gool F; Galli M; Gueydan C; Kruys V; Prevot PP; Bedalov A; Mostoslavsky R; Alt FW; De Smedt T; Leo O. 2009. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med 15(2):206-10. PubMed: 19151729 MGI: J:146526
Van Hove CL; Maes T; Joos GF; Tournoy KG. 2007. Prolonged inhaled allergen exposure can induce persistent tolerance. Am J Respir Cell Mol Biol 36(5):573-84. PubMed: 17218615 MGI: J:136611
VanLith ML; Kohlgraf KG; Sivinski CL; Tempero RM; Hollingsworth MA. 2002. MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses. Int Immunol 14(8):873-82. PubMed: 12147624 MGI: J:113544
Varadhachary AS; Monestier M; Salgame P. 2001. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cell Immunol 213(1):45-51. PubMed: 11747355 MGI: J:115363
Varma TK; Durham M; Murphey ED; Cui W; Huang Z; Lin CY; Toliver-Kinsky T; Sherwood ER. 2005. Endotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice. Infect Immun 73(11):7340-7. PubMed: 16239532 MGI: J:104229
Vasquez RE; Xin L; Soong L. 2008. Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection. Infect Immun 76(1):161-9. PubMed: 17998308 MGI: J:130175
Verhasselt V; Milcent V; Cazareth J; Kanda A; Fleury S; Dombrowicz D; Glaichenhaus N; Julia V. 2008. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med 14(2):170-5. PubMed: 18223654 MGI: J:133564
Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R. 2012. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation 126(4):418-29. PubMed: 22705886 MGI: J:202207
Vijay-Kumar M; Sanders CJ; Taylor RT; Kumar A; Aitken JD; Sitaraman SV; Neish AS; Uematsu S; Akira S; Williams IR; Gewirtz AT. 2007. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 117(12):3909-21. PubMed: 18008007 MGI: J:130765
Villarino AV; Artis D; Bezbradica JS; Miller O; Saris CJ; Joyce S; Hunter CA. 2008. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. Int Immunol 20(6):739-52. PubMed: 18375937 MGI: J:136179
Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA. 2000. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice. Infect Immun 68(5):2837-44. PubMed: 10768980 MGI: J:61699
Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M. 2012. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice. PLoS One 7(12):e52043. PubMed: 23284865 MGI: J:195626
Walker WE; Goldstein DR. 2007. Neonatal B cells suppress innate toll-like receptor immune responses and modulate alloimmunity. J Immunol 179(3):1700-10. PubMed: 17641036 MGI: J:149945
Walsh KP; Brady MT; Finlay CM; Boon L; Mills KH. 2009. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 183(3):1577-86. PubMed: 19587018 MGI: J:151701
Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN. 1999. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 162(1):277-83. PubMed: 9886396 MGI: J:51636
Wang J; Cho S; Ueno A; Cheng L; Xu BY; Desrosiers MD; Shi Y; Yang Y. 2008. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation. J Immunol 181(4):2438-45. PubMed: 18684934 MGI: J:140188
Wang L; Gordon RA; Huynh L; Su X; Park Min KH; Han J; Arthur JS; Kalliolias GD; Ivashkiv LB. 2010. Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 32(4):518-30. PubMed: 20362473 MGI: J:160755
Wang Q; Fang CH; Hasselgren PO. 2001. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281(3):R1013-23. PubMed: 11507020 MGI: J:71507
Wang RX; Yu CR; Dambuza IM; Mahdi RM; Dolinska MB; Sergeev YV; Wingfield PT; Kim SH; Egwuagu CE. 2014. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 20(6):633-41. PubMed: 24743305 MGI: J:213242
Wang Y; Rickman BH; Poutahidis T; Schlieper K; Jackson EA; Erdman SE; Fox JG; Horwitz BH. 2008. c-Rel is essential for the development of innate and T cell-induced colitis. J Immunol 180(12):8118-25. PubMed: 18523276 MGI: J:137235
Ward MA; Pierre JF; Leal RF; Huang Y; Shogan B; Dalal SR; Weber CR; Leone VA; Musch MW; An GC; Rao MC; Rubin DT; Raffals LE; Antonopoulos DA; Sogin ML; Hyman NH; Alverdy JC; Chang EB. 2016. Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility. Am J Physiol Gastrointest Liver Physiol 310(11):G973-88. PubMed: 27079612 MGI: J:235175
Weaver BK; Bohn E; Judd BA; Gil MP; Schreiber RD. 2007. ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions. Mol Cell Biol 27(13):4603-16. PubMed: 17485448 MGI: J:122758
Weiss KA; Christiaansen AF; Fulton RB; Meyerholz DK; Varga SM. 2011. Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol 187(6):3145-54. PubMed: 21844390 MGI: J:179242
Whary MT; Danon SJ; Feng Y; Ge Z; Sundina N; Ng V; Taylor NS; Rogers AB; Fox JG. 2006. Rapid onset of ulcerative typhlocolitis in B6.129P2-IL10tm1Cgn (IL-10-/-) mice infected with Helicobacter trogontum is associated with decreased colonization by altered Schaedler's flora. Infect Immun 74(12):6615-23. PubMed: 16982822 MGI: J:115918
Whary MT; Taylor NS; Feng Y; Ge Z; Muthupalani S; Versalovic J; Fox JG. 2011. Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. Immunology 133(2):165-78. PubMed: 21426337 MGI: J:173794
White CA; Johansson M; Roberts CT; Ramsay AJ; Robertson SA. 2004. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod 70(1):123-31. PubMed: 13679317 MGI: J:89857
Wilson EH; Wille-Reece U; Dzierszinski F; Hunter CA. 2005. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165(1-2):63-74. PubMed: 16005735 MGI: J:112764
Wilson MS; Elnekave E; Mentink-Kane MM; Hodges MG; Pesce JT; Ramalingam TR; Thompson RW; Kamanaka M; Flavell RA; Keane-Myers A; Cheever AW; Wynn TA. 2007. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 117(10):2941-51. PubMed: 17885690 MGI: J:127527
Wilson MS; Taylor MD; Balic A; Finney CA; Lamb JR; Maizels RM. 2005. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202(9):1199-212. PubMed: 16275759 MGI: J:118754
Winer S; Chan Y; Paltser G; Truong D; Tsui H; Bahrami J; Dorfman R; Wang Y; Zielenski J; Mastronardi F; Maezawa Y; Drucker DJ; Engleman E; Winer D; Dosch HM. 2009. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15(8):921-9. PubMed: 19633657 MGI: J:152185
Winstead CJ; Reilly CS; Moon JJ; Jenkins MK; Hamilton SE; Jameson SC; Way SS; Khoruts A. 2010. CD4(+)CD25(+)Foxp3(+) regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopenia. J Immunol 184(9):4749-60. PubMed: 20357265 MGI: J:160453
Wittig BM; Johansson B; Zoller M; Schwarzler C; Gunthert U. 2000. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med 191(12):2053-64. PubMed: 10859330 MGI: J:62867
Wohlleben G; Trujillo C; Muller J; Ritze Y; Grunewald S; Tatsch U; Erb KJ. 2004. Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 16(4):585-96. PubMed: 15039389 MGI: J:89202
Wojciechowski W; Harris DP; Sprague F; Mousseau B; Makris M; Kusser K; Honjo T; Mohrs K; Mohrs M; Randall T; Lund FE. 2009. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 30(3):421-33. PubMed: 19249230 MGI: J:146768
Wolfe DN; Karanikas AT; Hester SE; Kennett MJ; Harvill ET. 2010. IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol 184(3):1392-400. PubMed: 20042578 MGI: J:159527
Wu R; Li Y; Guo Z; Gong J; Zhu W; Li N; Li J. 2013. Triptolide ameliorates ileocolonic anastomosis inflammation in IL-10 deficient mice by mechanism involving suppression of miR-155/SHIP-1 signaling pathway. Mol Immunol 56(4):340-6. PubMed: 23911388 MGI: J:202099
Wynn TA; Cheever AW; Williams ME; Hieny S; Caspar P; Kuhn R; Muller W; Sher A. 1998. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 160(9):4473-80. PubMed: 9574553 MGI: J:119887
Wynn TA; Morawetz R; Scharton-Kersten T; Hieny S; Morse HC 3rd ; Kuhn R ; Muller W ; Cheever AW ; Sher A. 1997. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol 159(10):5014-23. PubMed: 9366429 MGI: J:44069
Xavier MN; Winter MG; Spees AM; Nguyen K; Atluri VL; Silva TM; Baumler AJ; Muller W; Santos RL; Tsolis RM. 2013. CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLoS Pathog 9(6):e1003454. PubMed: 23818855 MGI: J:213384
Xia ZW; Xu LQ; Zhong WW; Wei JJ; Li NL; Shao J; Li YZ; Yu SC; Zhang ZL. 2007. Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1. Am J Pathol 171(6):1904-14. PubMed: 17991714 MGI: J:129098
Xu L; Yin W; Sun R; Wei H; Tian Z. 2013. Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. Proc Natl Acad Sci U S A 110(42):16993-8. PubMed: 24089450 MGI: J:201989
Xue X; Feng T; Yao S; Wolf KJ; Liu CG; Liu X; Elson CO; Cong Y. 2011. Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol 187(11):5879-86. PubMed: 22068236 MGI: J:179678
Yan F; John SK; Wilson G; Jones DS; Washington MK; Polk DB. 2004. Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J Clin Invest 114(9):1272-80. PubMed: 15520859 MGI: J:94534
Yan X; Hegab AE; Endo J; Anzai A; Matsuhashi T; Katsumata Y; Ito K; Yamamoto T; Betsuyaku T; Shinmura K; Shen W; Vivier E; Fukuda K; Sano M. 2014. Lung natural killer cells play a major counter-regulatory role in pulmonary vascular hyperpermeability after myocardial infarction. Circ Res 114(4):637-49. PubMed: 24366170 MGI: J:223700
Yanaba K; Bouaziz JD; Haas KM; Poe JC; Fujimoto M; Tedder TF. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28(5):639-50. PubMed: 18482568 MGI: J:136340
Yanaba K; Bouaziz JD; Matsushita T; Tsubata T; Tedder TF. 2009. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 182(12):7459-72. PubMed: 19494269 MGI: J:149301
Yanaba K; Kamata M; Ishiura N; Shibata S; Asano Y; Tada Y; Sugaya M; Kadono T; Tedder TF; Sato S. 2013. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J Leukoc Biol 94(4):563-73. PubMed: 23630391 MGI: J:202646
Yang F; Dong A; Mueller P; Caicedo J; Sutton AM; Odetunde J; Barrick CJ; Klyachkin YM; Abdel-Latif A; Smyth SS. 2012. Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells. PLoS One 7(8):e40196. PubMed: 22916095 MGI: J:190055
Yang HT; Wang Y; Zhao X; Demissie E; Papoutsopoulou S; Mambole A; O'Garra A; Tomczak MF; Erdman SE; Fox JG; Ley SC; Horwitz BH. 2011. NF-(kappa)B1 inhibits TLR-induced IFN-(beta) production in macrophages through TPL-2-dependent ERK activation. J Immunol 186(4):1989-96. PubMed: 21217011 MGI: J:169175
Yang I; Eibach D; Kops F; Brenneke B; Woltemate S; Schulze J; Bleich A; Gruber AD; Muthupalani S; Fox JG; Josenhans C; Suerbaum S. 2013. Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS One 8(8):e70783. PubMed: 23951007 MGI: J:204929
Yang M; Deng J; Liu Y; Ko KH; Wang X; Jiao Z; Wang S; Hua Z; Sun L; Srivastava G; Lau CS; Cao X; Lu L. 2012. IL-10-Producing Regulatory B10 Cells Ameliorate Collagen-Induced Arthritis via Suppressing Th17 Cell Generation. Am J Pathol 180(6):2375-85. PubMed: 22538089 MGI: J:184805
Yang M; Sun L; Wang S; Ko KH; Xu H; Zheng BJ; Cao X; Lu L. 2010. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 184(7):3321-5. PubMed: 20208006 MGI: J:160064
Yang X; Wang S; Fan Y; Han X. 2000. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur J Immunol 30(2):382-91. PubMed: 10671193 MGI: J:60381
Yang Y; Huycke MM; Herman TS; Wang X. 2016. Glutathione S-transferase alpha 4 induction by activator protein 1 in colorectal cancer. Oncogene 35(44):5795-5806. PubMed: 27065323 MGI: J:237932
Yang Z; Zhang X; Darrah PA; Mosser DM. 2010. The Regulation of Th1 Responses by the p38 MAPK. J Immunol 185(10):6205-13. PubMed: 20937847 MGI: J:165637
Yao Y; Li W; Kaplan MH; Chang CH. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 201(12):1899-903. PubMed: 15967820 MGI: J:99206
Yen D; Cheung J; Scheerens H; Poulet F; McClanahan T; McKenzie B; Kleinschek MA; Owyang A; Mattson J; Blumenschein W; Murphy E; Sathe M; Cua DJ; Kastelein RA; Rennick D. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116(5):1310-6. PubMed: 16670770 MGI: J:108946
Yin S; Wang H; Park O; Wei W; Shen J; Gao B. 2011. Enhanced Liver Regeneration in IL-10-Deficient Mice after Partial Hepatectomy via Stimulating Inflammatory Response and Activating Hepatocyte STAT3. Am J Pathol 178(4):1614-21. PubMed: 21435447 MGI: J:169853
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J. 2002. IL-10 regulates murine lupus. J Immunol 169(4):2148-55. PubMed: 12165544 MGI: J:78239
Yoshizaki A; Miyagaki T; DiLillo DJ; Matsushita T; Horikawa M; Kountikov EI; Spolski R; Poe JC; Leonard WJ; Tedder TF. 2012. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491(7423):264-8. PubMed: 23064231 MGI: J:189218
Young A; Linehan E; Hams E; O'Hara Hall AC; McClurg A; Johnston JA; Hunter CA; Fallon PG; Fitzgerald DC. 2012. Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27. J Immunol 189(5):2079-83. PubMed: 22837488 MGI: J:189868
Zediak VP; Hunter CA. 2003. IL-10 fails to inhibit the production of IL-18 in response to inflammatory stimuli. Cytokine 21(2):84-90. PubMed: 12670447 MGI: J:128186
Zemse SM; Chiao CW; Hilgers RH; Webb RC. 2010. Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-{alpha} on the endothelium of murine aorta. Am J Physiol Heart Circ Physiol :. PubMed: 20639218 MGI: J:162772
Zhang B; Maris CH; Foell J; Whitmire J; Niu L; Song J; Kwon BS; Vella AT; Ahmed R; Jacob J; Mittler RS. 2007. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J Clin Invest 117(10):3029-41. PubMed: 17853940 MGI: J:127406
Zhang H; Stolz DB; Chalasani G; Thomson AW. 2013. Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells. Clin Exp Immunol 173(3):473-9. PubMed: 23617623 MGI: J:200639
Zhang L; Yuan S; Cheng G; Guo B. 2011. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS One 6(12):e28432. PubMed: 22163016 MGI: J:182267
Zhang N; Schroppel B; Lal G; Jakubzick C; Mao X; Chen D; Yin N; Jessberger R; Ochando JC; Ding Y; Bromberg JS. 2009. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30(3):458-69. PubMed: 19303390 MGI: J:147032
Zhang R; Li Q; Chuang PY; Lu G; Liu R; Yang J; Peng L; Dai Y; Zheng Z; Qi CF; He JC; Xiong H. 2013. Regulation of pathogenic th17 cell differentiation by IL-10 in the development of glomerulonephritis. Am J Pathol 183(2):402-12. PubMed: 23747510 MGI: J:198724
Zhang R; Li Y; Beck PL; McCafferty DM. 2007. Toll-like receptor 4 regulates colitis-associated adenocarcinoma development in interleukin-10-deficient (IL-10(-/-)) mice. Biochem Soc Trans 35(Pt 5):1375-6. PubMed: 17956355 MGI: J:131228
Zhang R; Ma A; Urbanski SJ; McCafferty DM. 2007. Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma. Carcinogenesis 28(5):1122-30. PubMed: 17116728 MGI: J:121056
Zhang X; Deriaud E; Jiao X; Braun D; Leclerc C; Lo-Man R. 2007. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med 204(5):1107-18. PubMed: 17485512 MGI: J:125728
Zhang X; Hester SE; Kennett MJ; Karanikas AT; Bendor L; Place DE; Harvill ET. 2011. Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun 79(1):527-41. PubMed: 20974829 MGI: J:167554
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD. 2007. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology 132(4):1331-43. PubMed: 17408649 MGI: J:203619
Zhao Z; Ciric B; Yu S; Zhang GX; Rostami A. 2010. Targeting ganglioside epitope 3G11 on the surface of CD4+ T cells suppresses EAE by altering the Treg/Th17 cell balance. Int Immunol 22(10):817-26. PubMed: 20679513 MGI: J:164321
Zhong J; Deaciuc IV; Burikhanov R; de Villiers WJ. 2006. Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice. Biochim Biophys Acta 1762(4):468-77. PubMed: 16497487 MGI: J:110238
Zhong Y; Cantwell A; Dube PH. 2010. Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut. Infect Immun 78(9):3716-25. PubMed: 20584975 MGI: J:163014
Zhou D; Collins CA; Wu P; Brown EJ. 2010. Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase. J Leukoc Biol 87(5):845-55. PubMed: 20145200 MGI: J:160352
Zhou F; Ciric B; Li H; Yan Y; Li K; Cullimore M; Lauretti E; Gonnella P; Zhang GX; Rostami A. 2012. IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells. Eur J Immunol 42(6):1449-58. PubMed: 22622800 MGI: J:187763
Zhou P; Streutker C; Borojevic R; Wang Y; Croitoru K. 2004. IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy. Am J Physiol Gastrointest Liver Physiol 287(3):G599-604. PubMed: 15331352 MGI: J:96079
Zhu X; Messer JS; Wang Y; Lin F; Cham CM; Chang J; Billiar TR; Lotze MT; Boone DL; Chang EB. 2015. Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. J Clin Invest 125(3):1098-110. PubMed: 25642769 MGI: J:220375
Zhu Y; Mahon BD; Froicu M; Cantorna MT. 2005. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35(1):217-24. PubMed: 15593122 MGI: J:95228
Zimmermann S; Murray PJ; Heeg K; Dalpke AH. 2006. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling. J Immunol 176(3):1840-7. PubMed: 16424215 MGI: J:126418
Zohar Y; Wildbaum G; Novak R; Salzman AL; Thelen M; Alon R; Barsheshet Y; Karp CL; Karin N. 2014. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. J Clin Invest 124(5):2009-22. PubMed: 24713654 MGI: J:212764
Zou Q; Wu B; Xue J; Fan X; Feng C; Geng S; Wang M; Wang B. 2014. CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection. Eur J Immunol 44(1):103-14. PubMed: 24114149 MGI: J:208656
de Buhr MF; Hedrich HJ; Westendorf AM; Obermeier F; Hofmann C; Zschemisch NH; Buer J; Bumann D; Goyert SM; Bleich A. 2009. Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice. Inflamm Bowel Dis 15(12):1824-1836. PubMed: 19637338 MGI: J:154082
de Koning BA; van Dieren JM; Lindenbergh-Kortleve DJ; van der Sluis M; Matsumoto T; Yamaguchi K; Einerhand AW; Samsom JN; Pieters R; Nieuwenhuis EE. 2006. Contributions of mucosal immune cells to methotrexate-induced mucositis. Int Immunol 18(6):941-9. PubMed: 16636014 MGI: J:109135
de Ledesma AM; Desai AN; Bolivar VJ; Symula DJ; Flaherty L. 2006. Two new behavioral QTLs, Emo4 and Reb1, map to mouse Chromosome 1: Congenic strains and candidate gene identification studies. Mamm Genome 17(2):111-8. PubMed: 16465591 MGI: J:105315
den Boer MA; Voshol PJ; Schroder-van der Elst JP; Korsheninnikova E; Ouwens DM; Kuipers F; Havekes LM; Romijn JA. 2006. Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice. Endocrinology 147(10):4553-8. PubMed: 16709607 MGI: J:129479
van Den Broek M; Bachmann MF; Kohler G; Barner M; Escher R; Zinkernagel R; Kopf M. 2000. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol 164(1):371-8. PubMed: 10605032 MGI: J:125984
van der Sluis M; Bouma J; Vincent A; Velcich A; Carraway KL; Buller HA; Einerhand AW; van Goudoever JB; Van Seuningen I; Renes IB. 2008. Combined defects in epithelial and immunoregulatory factors exacerbate the pathogenesis of inflammation: mucin 2-interleukin 10-deficient mice. Lab Invest 88(6):634-42. PubMed: 18427556 MGI: J:136253

Also Known As: Il-10 KO

Donating Investigator

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Control Suggestions

Additional Information

Selected References

Il10tm1Cgn

Allele Symbol: Il10tm1Cgn

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Il10tm1Cgn related

Mammalian Phenotype Terms by Genotype

Genotype: Il10tm1Cgn/Il10tm1CgnB6.129P2-Il10tm1Cgn

immune system phenotype

homeostasis/metabolism phenotype

Genotype: Il10tm1Cgn/Il10tm1CgnB6.129P2-Il10tm1Cgn/J

growth/size/body region phenotype

neoplasm

cellular phenotype

hematopoietic system phenotype

immune system phenotype

homeostasis/metabolism phenotype

digestive/alimentary phenotype

cardiovascular system phenotype

muscle phenotype

behavior/neurological phenotype

nervous system phenotype

vision/eye phenotype

Genotype: Il10tm1Cgn/Il10tm1Cgninvolves: 129P2/OlaHsd

reproductive system phenotype

immune system phenotype

digestive/alimentary phenotype

homeostasis/metabolism phenotype

Genotype: Il10tm1Cgn/Il10tm1Cgninvolves: 129P2/OlaHsd * C57BL/6 * DBA/1

growth/size/body region phenotype

digestive/alimentary phenotype

immune system phenotype

Genotype: Il10tm1Cgn/Il10tm1Cgninvolves: 129P2/OlaHsd * 129S/SvEv

growth/size/body region phenotype

digestive/alimentary phenotype

immune system phenotype

Genotype: Il10tm1Cgn/Il10tm1CgnB10.129P2(B6)-Il10tm1Cgn/J

immune system phenotype

Genotype: Il10tm1Cgn/Il10tm1Cgn129S.Cg-Il10tm1Cgn

cardiovascular system phenotype

muscle phenotype

Genotype: Il10tm1Cgn/Il10tm1Cgninvolves: 129P2/OlaHsd * C57BL/6

mortality/aging

behavior/neurological phenotype

cardiovascular system phenotype

craniofacial phenotype

embryo phenotype

limbs/digits/tail phenotype

liver/biliary system phenotype

skeleton phenotype

integument phenotype

cellular phenotype

digestive/alimentary phenotype

growth/size/body region phenotype

hematopoietic system phenotype

immune system phenotype

neoplasm

respiratory system phenotype

homeostasis/metabolism phenotype

endocrine/exocrine gland phenotype

References

Additional References

Additional - Il10tm1Cgn related

Genotyping Protocols

Dietary Information

Breeding Considerations

Mating System

Appearance

Animal Health Reports

Live Mouse

Il10^tm1Cgn

Allele Symbol: Il10^tm1Cgn

Genotype: Il10^tm1Cgn related

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
B6.129P2-Il10^tm1Cgn

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
B6.129P2-Il10^tm1Cgn/J

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd * C57BL/6 * DBA/1

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd * 129S/SvEv

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
B10.129P2(B6)-Il10^tm1Cgn/J

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
129S.Cg-Il10^tm1Cgn

Genotype: Il10^tm1Cgn/Il10^tm1Cgn
involves: 129P2/OlaHsd * C57BL/6

Additional - Il10^tm1Cgn related